≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Burn and corrosion of ankle and foot

MESH Endpoint Browser

ST19_BURN_CORROSION_ANKLE_FOOT

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T25
  • Cause of death: ICD-10 — T25

2 out of 7 registries used, show all original rules.

554

4. Check minimum number of events

None

554

5. Include endpoints

None

554

6. Filter based on genotype QC (FinnGen only)

534

Control definitions (FinnGen only)

Control exclude
CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T2[0-5]
Name in latin
Combustiones et corrosiones tarsi et pedis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 534 216 318
Unadjusted period prevalence (%) 0.12 0.08 0.15
Median age at first event (years) 53.06 50.13 55.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
554
Matched controls
5540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X12
ICD-10 Finland
Contact with other hot fluids
281.8
307.7
187
10
T25.2
ICD-10 Finland
Burn of second degree of ankle and foot
+∞
307.7
343
*
S14
ICPC
Burn/scald
28.0
235.3
174
89
T25.3
ICD-10 Finland
Burn of third degree of ankle and foot
+∞
113.5
105
*
QDD20
NOMESCO Finland
Excision of burn of lower limb and coverage
384.2
97.3
95
*
T25.0
ICD-10 Finland
Burn of unspecified degree of ankle and foot
+∞
95.7
89
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
10.2
88.5
110
131
T25.1
ICD-10 Finland
Burn of first degree of ankle and foot
475.9
84.4
82
*
ZZA00
NOMESCO Finland
Split skin graft
12.8
81.6
84
76
QDD00
NOMESCO Finland
Dressing of major burn of lower limb
836.6
76.2
73
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.6
47.9
139
377
T24.2
ICD-10 Finland
Burn of second degree of hip and lower limb, except ankle and foot
59.7
33.7
39
7
X59
ICD-10 Finland
Exposure to unspecified factor
3.1
31.6
172
694
X18
ICD-10 Finland
Contact with other hot metals
53.2
29.7
35
7
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.6
25.3
42
68
X19
ICD-10 Finland
Contact with other and unspecified heat and hot substances
73.4
25.0
28
*
S97
ICPC
Chronic ulcer skin
4.1
22.2
65
173
R4120
NOMESCO Finland
Occupational therapy
4.0
22.1
67
183
NHQ40
NOMESCO Finland
Amputation of toe
8.8
21.2
27
32
TQW10
NOMESCO Finland
Exchange of bandage for burn
80.0
20.8
23
*
QDD10
NOMESCO Finland
Debridement of burn of lower limb
80.0
20.8
23
*
X58
ICD-10 Finland
Exposure to other specified factors
2.7
20.7
135
587
T24.3
ICD-10 Finland
Burn of third degree of hip and lower limb, except ankle and foot
59.8
20.0
23
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.0
19.3
43
92
T31.0
ICD-10 Finland
Burns involving less than 10% of body surface
92.9
16.7
18
*
X14
ICD-10 Finland
Contact with hot air and gases
87.6
15.6
17
*
T95.3
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of lower limb
+∞
13.6
13
*
T25.4
ICD-10 Finland
Corrosion of unspecified degree of ankle and foot
+∞
13.6
13
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.5
12.9
25
47
T25
ICD-10 Finland
Burn and corrosion of ankle and foot
+∞
12.5
12
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
11.8
84
374
T21.2
ICD-10 Finland
Burn of second degree of trunk
30.8
11.7
15
5
T24.0
ICD-10 Finland
Burn of unspecified degree of hip and lower limb, except ankle and foot
66.4
11.6
13
*
N03AX16
ATC
[U] pregabalin
2.0
10.7
133
743
T23.2
ICD-10 Finland
Burn of second degree of wrist and hand
8.8
10.6
22
26
T24.1
ICD-10 Finland
Burn of first degree of hip and lower limb, except ankle and foot
+∞
10.4
10
*
T25.5
ICD-10 Finland
Corrosion of first degree of ankle and foot
+∞
10.4
10
*
X00
ICD-10 Finland
Exposure to uncontrolled fire in building or structure
33.2
10.4
13
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.5
10.1
25
58
ZXD05
NOMESCO Finland
Urgent procedure
1.9
10.0
176
1103
C03CA01
ATC
furosemide; systemic
1.9
10.0
153
917
S18
ICPC
Laceration/cut
1.8
9.9
268
1913
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.7
9.9
23
51
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
26.6
9.8
13
5
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
10.9
9.8
18
17
A46
ICD-10 Finland
Erysipelas
2.2
9.8
94
475
QDB10, ,
SPAT
4.2
9.8
26
64
A10AB05
ATC
insulin aspart; parenteral
2.6
9.7
58
237
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.4
9.7
19
36
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.6
9.5
59
246
X04
ICD-10 Finland
Exposure to ignition of highly flammable material
101.7
9.4
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
9.0
100
533
W92
ICD-10 Finland
Exposure to excessive heat of man-made origin
37.3
9.0
11
*
J01FF01
ATC
clindamycin; systemic
1.9
9.0
153
944
AA1AD
NOMESCO Finland
CT of head and brain
1.8
9.0
159
994
A10AE05
ATC
insulin detemir; parenteral
2.9
9.0
42
151
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
8.9
76
365
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
4.6
8.9
21
47
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
8.7
39
137
J01DB01
ATC
cefalexin; oral
2.0
8.6
457
3902
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
8.4
43
162
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
8.4
55
235
T30.0
ICD-10 Finland
Burn of unspecified body region, unspecified degree
22.4
8.0
11
5
A10AC01
ATC
insulin (human); parenteral
2.5
8.0
53
228
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.0
7.9
35
122
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
15.3
7.7
12
8
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
7.6
167
1105
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.4
7.5
26
78
H3603, E103,
ICD-10 Finland
9.5
7.3
14
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.3
253
1882
X06
ICD-10 Finland
Exposure to ignition or melting of other clothing and apparel
+∞
7.3
7
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.4
7.3
18
42
QCD00
NOMESCO Finland
Dressing of major burn of upper limb
16.0
7.3
11
7
T29.2
ICD-10 Finland
Burns of multiple regions, no more than second-degree burns mentioned
30.4
7.2
9
*
A10AA02, ,
ATC
3.2
7.1
28
91
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.0
202
1430
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
7.0
40
160
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
7.7
6.9
15
20
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
6.9
64
319
H36.00
ICD-10 Finland
Diabetic background retinopathy
5.8
6.8
18
32
N05CF01
ATC
zopiclone; oral
1.7
6.8
168
1143
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
6.8
147
965
SPAT1211
SPAT
Application of soft bandage
2.3
6.8
52
239
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
6.7
180
1249
A10AE04
ATC
insulin glargine; parenteral
2.2
6.7
61
301
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
22.8
6.7
9
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
6.6
53
248
A06AD11
ATC
lactulose; oral
2.0
6.6
77
417
L17
ICPC
Foot/toe symptom/complaint
1.7
6.6
163
1108
SPAT1260
SPAT
Consultation of another employee
1.9
6.6
93
538
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
6.6
32
118
M79.6
ICD-10 Finland
Pain in limb
1.6
6.5
232
1724
SPAT1301
SPAT
No procedures
1.7
6.5
159
1077
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.1
6.5
60
298
W99
ICD-10 Finland
Exposure to other and unspecified man-made environmental factors
14.5
6.4
10
7
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.8
6.4
19
51
WX213
NOMESCO Finland
Lower leg blockade
9.4
6.3
12
13
X01
ICD-10 Finland
Exposure to uncontrolled fire, not in building or structure
+∞
6.3
6
*
QDD00, ,
SPAT
+∞
6.3
6
*
T25.7
ICD-10 Finland
Corrosion of third degree of ankle and foot
+∞
6.3
6
*
T25.6
ICD-10 Finland
Corrosion of second degree of ankle and foot
+∞
6.3
6
*
S01.0
ICD-10 Finland
Open wound of scalp
2.3
6.2
49
229
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
6.0
25
84

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
1.2e+00
1.9e+00
3.6e+00
1.0e+50
4.7e+00
3.0e+00
1.1e+00
cases:4.10%
controls:1.28%
cases:3.16%
controls:0.50%
cases:5.58%
controls:0.17%
cases:1.30%
controls:0.00%
cases:13.81%
controls:0.15%
cases:8.95%
controls:0.50%
cases:4.71%
controls:1.56%
22
69
515
5301
17
27
521
5349
30
9
508
5367
7
0
531
5376
74
8
462
5359
46
26
468
5170
21
70
425
4419
Laceration/cut
S18 [2002000983]
7.5e-01
1.0e+00
2.4e+00
—
3.8e+00
1.5e+00
8.1e-01
cases:13.04%
controls:6.63%
cases:6.88%
controls:2.55%
cases:3.72%
controls:0.33%
—
—
cases:9.14%
controls:0.22%
cases:9.34%
controls:2.23%
cases:16.37%
controls:8.00%
70
356
467
5014
37
137
501
5239
20
18
518
5358
—
49
12
487
5355
48
116
466
5080
73
359
373
4130
Plastic And Reconstructive Surgery
24 [38004467]
8.7e-01
1.4e+00
3.1e+00
1.0e+50
—
3.3e+00
1.6e+00
cases:5.21%
controls:2.25%
cases:3.53%
controls:0.87%
cases:3.53%
controls:0.17%
cases:21.93%
controls:0.00%
—
—
cases:18.68%
controls:0.81%
cases:10.31%
controls:2.36%
28
121
509
5249
19
47
519
5329
19
9
519
5367
118
0
420
5376
—
96
42
418
5154
46
106
400
4383
cefalexin; oral
J01DB01 [21602870]
4.4e-01
5.5e-01
2.8e+00
—
3.2e+00
9.3e-01
4.4e-01
cases:37.06%
controls:27.50%
cases:15.24%
controls:9.39%
cases:12.27%
controls:0.82%
—
—
cases:19.22%
controls:0.97%
cases:17.90%
controls:7.91%
cases:34.53%
controls:25.37%
199
1477
338
3893
82
505
456
4871
66
44
472
5332
—
103
52
433
5315
92
411
422
4785
154
1139
292
3350
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
4.5e-01
4.7e-01
1.1e+00
3.5e+00
1.8e+00
4.1e-01
5.2e-01
cases:39.29%
controls:29.26%
cases:22.30%
controls:15.20%
cases:6.69%
controls:2.34%
cases:2.97%
controls:0.09%
cases:13.81%
controls:2.68%
cases:22.18%
controls:15.90%
cases:47.31%
controls:34.75%
211
1571
326
3799
120
817
418
4559
36
126
502
5250
16
5
522
5371
74
144
462
5223
114
826
400
4370
211
1560
235
2929
Exposure to unspecified factor
X59 [45756412]
8.7e-01
1.8e+00
2.3e+00
1.0e+50
—
1.8e+00
1.2e+00
cases:5.21%
controls:2.25%
cases:2.97%
controls:0.50%
cases:1.12%
controls:0.11%
cases:8.36%
controls:0.00%
—
—
cases:4.47%
controls:0.73%
cases:7.40%
controls:2.34%
28
121
509
5249
16
27
522
5349
6
6
532
5370
45
0
493
5376
—
23
38
491
5158
33
105
413
4384
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.2e-01
2.5e-01
9.1e-01
4.1e+00
1.7e+00
5.8e-01
3.6e-01
cases:30.73%
controls:26.16%
cases:21.19%
controls:17.30%
cases:8.36%
controls:3.55%
cases:8.55%
controls:0.15%
cases:15.67%
controls:3.35%
cases:27.24%
controls:17.30%
cases:46.19%
controls:37.36%
165
1405
372
3965
114
930
424
4446
45
191
493
5185
46
8
492
5368
84
180
452
5187
140
899
374
4297
206
1677
240
2812
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
1.6e+00
1.8e+00
—
1.0e+50
—
3.9e+00
2.0e+00
cases:1.49%
controls:0.30%
cases:0.93%
controls:0.15%
—
—
cases:3.16%
controls:0.00%
—
—
cases:5.45%
controls:0.12%
cases:2.91%
controls:0.42%
8
16
529
5354
5
8
533
5368
—
17
0
521
5376
—
28
6
486
5190
13
19
433
4470
Emergency Room Visit
ER [9203]
8.1e-01
6.5e-01
1.9e+00
—
2.4e+00
7.7e-01
7.1e-01
cases:50.84%
controls:31.58%
cases:19.52%
controls:11.20%
cases:7.06%
controls:1.08%
—
—
cases:13.62%
controls:1.45%
cases:19.65%
controls:10.14%
cases:45.74%
controls:29.38%
273
1696
264
3674
105
602
433
4774
38
58
500
5318
—
73
78
463
5289
101
527
413
4669
204
1319
242
3170
Outpatient Visit
OP [9202]
1.9e-01
3.4e-01
5.6e-01
3.2e+00
1.8e+00
7.4e-01
4.6e-01
cases:71.14%
controls:67.15%
cases:54.28%
controls:45.70%
cases:16.54%
controls:10.17%
cases:12.45%
controls:0.58%
cases:39.55%
controls:9.45%
cases:64.01%
controls:45.94%
cases:82.29%
controls:74.54%
382
3606
155
1764
292
2457
246
2919
89
547
449
4829
67
31
471
5345
212
507
324
4860
329
2387
185
2809
367
3346
79
1143
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
6.6e-01
7.2e-01
2.3e+00
—
2.2e+00
1.0e+00
4.7e-01
cases:12.29%
controls:6.72%
cases:5.39%
controls:2.70%
cases:2.79%
controls:0.28%
—
—
cases:3.92%
controls:0.43%
cases:6.23%
controls:2.27%
cases:9.87%
controls:6.39%
66
361
471
5009
29
145
509
5231
15
15
523
5361
—
21
23
515
5344
32
118
482
5078
44
287
402
4202
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
—
2.2e+00
-1.0e+50
—
—
2.7e+00
2.0e+00
—
—
cases:1.12%
controls:0.13%
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.36%
controls:0.10%
cases:1.79%
controls:0.25%
—
6
7
532
5369
0
5
538
5371
—
—
7
5
507
5191
8
11
438
4478
General Practice
1 [38004446]
7.0e-01
6.5e-01
1.8e+00
—
2.4e+00
6.5e-01
6.4e-01
cases:21.60%
controls:12.05%
cases:8.74%
controls:4.76%
cases:3.16%
controls:0.56%
—
—
cases:9.33%
controls:0.89%
cases:9.73%
controls:5.35%
cases:23.32%
controls:13.88%
116
647
421
4723
47
256
491
5120
17
30
521
5346
—
50
48
486
5319
50
278
464
4918
104
623
342
3866
Occupational therapy
R4120 [2001310234]
1.4e+00
1.6e+00
—
1.0e+50
—
3.8e+00
1.5e+00
cases:2.61%
controls:0.65%
cases:0.93%
controls:0.19%
—
—
cases:1.49%
controls:0.00%
—
—
cases:4.28%
controls:0.10%
cases:2.47%
controls:0.53%
14
35
523
5335
5
10
533
5366
—
8
0
530
5376
—
22
5
492
5191
11
24
435
4465
Inpatient Hospital
21 [8717]
5.0e-01
7.7e-01
1.4e+00
—
2.6e+00
6.2e-01
7.2e-01
cases:42.09%
controls:30.69%
cases:19.70%
controls:10.19%
cases:4.65%
controls:1.15%
—
—
cases:17.35%
controls:1.49%
cases:16.34%
controls:9.51%
cases:35.87%
controls:21.32%
226
1648
311
3722
106
548
432
4828
25
62
513
5314
—
93
80
443
5287
84
494
430
4702
160
957
286
3532
General Surgery
2 [38004447]
4.1e-01
6.0e-01
1.3e+00
—
2.9e+00
9.6e-01
4.7e-01
cases:23.84%
controls:17.13%
cases:9.11%
controls:5.23%
cases:2.60%
controls:0.73%
—
—
cases:14.55%
controls:0.95%
cases:12.26%
controls:5.08%
cases:21.97%
controls:15.01%
128
920
409
4450
49
281
489
5095
14
39
524
5337
—
78
51
458
5316
63
264
451
4932
98
674
348
3815
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.8e-01
2.0e-01
6.2e-01
4.0e+00
1.5e+00
4.6e-01
2.0e-01
cases:31.66%
controls:27.97%
cases:25.46%
controls:21.86%
cases:7.25%
controls:4.02%
cases:7.81%
controls:0.15%
cases:14.37%
controls:3.75%
cases:30.35%
controls:21.61%
cases:46.19%
controls:41.28%
170
1502
367
3868
137
1175
401
4201
39
216
499
5160
42
8
496
5368
77
201
459
5166
156
1123
358
4073
206
1853
240
2636
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
1.1e+00
1.2e+00
—
1.0e+50
3.4e+00
2.0e+00
5.7e-01
cases:4.66%
controls:1.58%
cases:1.86%
controls:0.60%
—
—
cases:0.93%
controls:0.00%
cases:2.80%
controls:0.09%
cases:3.31%
controls:0.48%
cases:4.26%
controls:2.45%
25
85
512
5285
10
32
528
5344
—
5
0
533
5376
15
5
521
5362
17
25
497
5171
19
110
427
4379
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
2.1e+00
2.5e+00
—
—
1.0e+50
—
1.9e+00
cases:1.68%
controls:0.20%
cases:1.30%
controls:0.11%
—
—
—
—
cases:0.93%
controls:0.00%
—
—
cases:2.47%
controls:0.38%
9
11
528
5359
7
6
531
5370
—
—
5
0
531
5367
—
11
17
435
4472
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.7e-01
1.9e-01
6.1e-01
3.9e+00
1.4e+00
4.5e-01
2.0e-01
cases:31.66%
controls:28.18%
cases:25.46%
controls:22.06%
cases:7.25%
controls:4.09%
cases:7.81%
controls:0.17%
cases:14.37%
controls:3.88%
cases:30.74%
controls:22.02%
cases:46.41%
controls:41.59%
170
1513
367
3857
137
1186
401
4190
39
220
499
5156
42
9
496
5367
77
208
459
5159
158
1144
356
4052
207
1867
239
2622
Chronic ulcer skin
S97 [2002001061]
1.5e+00
1.9e+00
—
—
—
2.8e+00
2.0e+00
cases:1.68%
controls:0.39%
cases:1.12%
controls:0.17%
—
—
—
—
—
—
cases:3.11%
controls:0.19%
cases:4.93%
controls:0.67%
9
21
528
5349
6
9
532
5367
—
—
—
16
10
498
5186
22
30
424
4459
Emergency Medicine
93 [38004510]
7.0e-01
6.9e-01
1.8e+00
—
1.7e+00
7.3e-01
4.9e-01
cases:21.79%
controls:12.10%
cases:11.90%
controls:6.32%
cases:3.90%
controls:0.69%
—
—
cases:5.04%
controls:0.95%
cases:12.06%
controls:6.22%
cases:29.37%
controls:20.23%
117
650
420
4720
64
340
474
5036
21
37
517
5339
—
27
51
509
5316
62
323
452
4873
131
908
315
3581
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.5e+00
1.5e+00
—
—
—
1.7e+00
1.2e+00
cases:3.54%
controls:0.78%
cases:2.04%
controls:0.45%
—
—
—
—
—
—
cases:2.53%
controls:0.48%
cases:3.81%
controls:1.18%
19
42
518
5328
11
24
527
5352
—
—
—
13
25
501
5171
17
53
429
4436
codeine and paracetamol
N02AJ06 [1123647]
4.3e-01
7.9e-01
1.5e+00
—
2.0e+00
6.3e-01
4.3e-01
cases:18.81%
controls:13.11%
cases:9.67%
controls:4.63%
cases:3.53%
controls:0.82%
—
—
cases:5.78%
controls:0.80%
cases:8.95%
controls:4.97%
cases:18.61%
controls:12.90%
101
704
436
4666
52
249
486
5127
19
44
519
5332
—
31
43
505
5324
46
258
468
4938
83
579
363
3910
Outpatient Hospital
22 [8756]
4.4e-01
7.0e-01
1.1e+00
—
3.0e+00
8.5e-01
8.4e-01
cases:32.77%
controls:23.85%
cases:12.64%
controls:6.73%
cases:2.04%
controls:0.69%
—
—
cases:12.13%
controls:0.71%
cases:13.81%
controls:6.39%
cases:29.82%
controls:15.50%
176
1281
361
4089
68
362
470
5014
11
37
527
5339
—
65
38
471
5329
71
332
443
4864
133
696
313
3793
CBC panel - Blood by Automated count
58410-2 [40761511]
1.9e-01
2.3e-01
5.1e-01
3.8e+00
1.4e+00
4.7e-01
2.3e-01
cases:32.59%
controls:28.60%
cases:24.35%
controls:20.35%
cases:5.95%
controls:3.66%
cases:6.32%
controls:0.15%
cases:12.13%
controls:3.34%
cases:27.82%
controls:19.46%
cases:44.84%
controls:39.30%
175
1536
362
3834
131
1094
407
4282
32
197
506
5179
34
8
504
5368
65
179
471
5188
143
1011
371
4185
200
1764
246
2725
Burn/scald
S14 [2002000979]
1.4e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
—
2.2e+00
cases:1.49%
controls:0.35%
cases:2.79%
controls:0.09%
cases:10.41%
controls:0.00%
cases:4.46%
controls:0.00%
cases:23.32%
controls:0.00%
—
—
cases:1.35%
controls:0.16%
8
19
529
5351
15
5
523
5371
56
0
482
5376
24
0
514
5376
125
0
411
5367
—
6
7
440
4482
INR in Blood by Coagulation assay
34714-6 [3032080]
5.3e-01
2.6e-01
3.9e-01
3.3e+00
1.2e+00
5.2e-01
5.0e-01
cases:13.04%
controls:8.10%
cases:6.69%
controls:5.25%
cases:2.04%
controls:1.40%
cases:2.42%
controls:0.09%
cases:5.41%
controls:1.66%
cases:8.17%
controls:5.04%
cases:17.94%
controls:11.72%
70
435
467
4935
36
282
502
5094
11
75
527
5301
13
5
525
5371
29
89
507
5278
42
262
472
4934
80
526
366
3963
Case Management Agency
251B00000X [38004193]
4.9e-02
7.2e-02
6.8e-01
3.7e+00
1.1e+00
2.3e-01
2.0e-01
cases:62.01%
controls:60.86%
cases:54.28%
controls:52.47%
cases:32.53%
controls:19.64%
cases:33.27%
controls:1.23%
cases:44.78%
controls:21.43%
cases:59.34%
controls:53.77%
cases:73.54%
controls:69.50%
333
3268
204
2102
292
2821
246
2555
175
1056
363
4320
179
66
359
5310
240
1150
296
4217
305
2794
209
2402
328
3120
118
1369
Psychiatry
26 [38004469]
6.3e-01
7.7e-01
1.2e+00
—
1.3e+00
8.4e-01
6.7e-01
cases:9.87%
controls:5.53%
cases:6.51%
controls:3.11%
cases:3.35%
controls:1.04%
—
—
cases:3.54%
controls:1.01%
cases:6.42%
controls:2.89%
cases:10.99%
controls:5.95%
53
297
484
5073
35
167
503
5209
18
56
520
5320
—
19
54
517
5313
33
150
481
5046
49
267
397
4222
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.9e-03
6.9e-02
3.7e-01
4.1e+00
1.2e+00
1.8e-01
-1.2e-01
cases:25.88%
controls:25.81%
cases:20.82%
controls:19.70%
cases:5.58%
controls:3.91%
cases:5.39%
controls:0.09%
cases:11.75%
controls:3.78%
cases:23.54%
controls:20.40%
cases:35.20%
controls:38.03%
139
1386
398
3984
112
1059
426
4317
30
210
508
5166
29
5
509
5371
63
203
473
5164
121
1060
393
4136
157
1707
289
2782
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
9.1e-02
1.6e-01
5.4e-01
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:33.15%
controls:31.15%
cases:29.00%
controls:25.78%
cases:8.92%
controls:5.39%
cases:7.81%
controls:0.26%
cases:16.23%
controls:5.05%
cases:35.02%
controls:26.12%
cases:49.55%
controls:45.73%
178
1673
359
3697
156
1386
382
3990
48
290
490
5086
42
14
496
5362
87
271
449
5096
180
1357
334
3839
221
2053
225
2436
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.6e-01
1.0e-01
4.1e-01
3.5e+00
1.3e+00
4.3e-01
4.3e-02
cases:23.84%
controls:21.04%
cases:19.33%
controls:17.76%
cases:5.76%
controls:3.89%
cases:6.13%
controls:0.20%
cases:11.75%
controls:3.63%
cases:24.90%
controls:17.78%
cases:34.98%
controls:34.02%
128
1130
409
4240
104
955
434
4421
31
209
507
5167
33
11
505
5365
63
195
473
5172
128
924
386
4272
156
1527
290
2962
Nephrology
39 [38004479]
1.2e+00
1.3e+00
—
—
1.4e+00
1.4e+00
1.3e+00
cases:2.42%
controls:0.73%
cases:2.23%
controls:0.63%
—
—
—
—
cases:0.93%
controls:0.24%
cases:2.72%
controls:0.69%
cases:3.59%
controls:1.05%
13
39
524
5331
12
34
526
5342
—
—
5
13
531
5354
14
36
500
5160
16
47
430
4442
Platelets [#/volume] in Blood
26515-7 [3007461]
9.9e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.5e-01
1.2e-01
cases:36.50%
controls:34.25%
cases:32.34%
controls:29.02%
cases:9.85%
controls:6.21%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.94%
cases:37.35%
controls:29.48%
cases:52.91%
controls:49.86%
196
1839
341
3531
174
1560
364
3816
53
334
485
5042
45
15
493
5361
95
319
441
5048
192
1532
322
3664
236
2238
210
2251
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
9.8e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.5e-01
1.2e-01
cases:36.69%
controls:34.43%
cases:32.53%
controls:29.11%
cases:9.85%
controls:6.23%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.94%
cases:37.35%
controls:29.62%
cases:52.91%
controls:49.90%
197
1849
340
3521
175
1565
363
3811
53
335
485
5041
45
15
493
5361
95
319
441
5048
192
1539
322
3657
236
2240
210
2249
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.0e-01
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.5e-01
1.2e-01
cases:36.87%
controls:34.49%
cases:32.53%
controls:29.17%
cases:9.85%
controls:6.23%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.94%
cases:37.35%
controls:29.68%
cases:52.91%
controls:50.01%
198
1852
339
3518
175
1568
363
3808
53
335
485
5041
45
15
493
5361
95
319
441
5048
192
1542
322
3654
236
2245
210
2244
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
9.8e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.5e-01
1.2e-01
cases:36.69%
controls:34.45%
cases:32.53%
controls:29.17%
cases:9.85%
controls:6.23%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.96%
cases:37.35%
controls:29.62%
cases:52.91%
controls:49.94%
197
1850
340
3520
175
1568
363
3808
53
335
485
5041
45
15
493
5361
95
320
441
5047
192
1539
322
3657
236
2242
210
2247
MCH [Entitic mass]
28539-5 [3035941]
9.9e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.4e-01
1.2e-01
cases:36.69%
controls:34.41%
cases:32.53%
controls:29.07%
cases:9.85%
controls:6.21%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.94%
cases:37.16%
controls:29.60%
cases:52.91%
controls:49.92%
197
1848
340
3522
175
1563
363
3813
53
334
485
5042
45
15
493
5361
95
319
441
5048
191
1538
323
3658
236
2241
210
2248
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
9.8e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.4e-01
1.2e-01
cases:36.69%
controls:34.43%
cases:32.53%
controls:29.13%
cases:9.85%
controls:6.23%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.96%
cases:37.16%
controls:29.62%
cases:52.91%
controls:49.99%
197
1849
340
3521
175
1566
363
3810
53
335
485
5041
45
15
493
5361
95
320
441
5047
191
1539
323
3657
236
2244
210
2245
Leukocytes [#/volume] in Blood
26464-8 [3010813]
9.7e-02
1.6e-01
5.0e-01
3.5e+00
1.2e+00
3.4e-01
1.2e-01
cases:36.69%
controls:34.47%
cases:32.53%
controls:29.19%
cases:9.85%
controls:6.21%
cases:8.36%
controls:0.28%
cases:17.72%
controls:5.98%
cases:37.16%
controls:29.64%
cases:52.91%
controls:50.01%
197
1851
340
3519
175
1569
363
3807
53
334
485
5042
45
15
493
5361
95
321
441
5046
191
1540
323
3656
236
2245
210
2244
Physiotherapy
R4110 [2001310233]
4.0e-01
4.2e-01
1.8e+00
1.0e+50
3.6e+00
1.3e+00
5.6e-01
cases:6.52%
controls:4.45%
cases:2.60%
controls:1.73%
cases:0.93%
controls:0.15%
cases:1.86%
controls:0.00%
cases:4.66%
controls:0.13%
cases:4.28%
controls:1.19%
cases:7.17%
controls:4.21%
35
239
502
5131
14
93
524
5283
5
8
533
5368
10
0
528
5376
25
7
511
5360
22
62
492
5134
32
189
414
4300
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
5.4e-01
9.0e-01
—
—
3.2e+00
8.1e-01
4.4e-01
cases:7.45%
controls:4.49%
cases:5.39%
controls:2.27%
—
—
—
—
cases:2.99%
controls:0.13%
cases:4.86%
controls:2.21%
cases:8.52%
controls:5.68%
40
241
497
5129
29
122
509
5254
—
—
16
7
520
5360
25
115
489
5081
38
255
408
4234
pregabalin; oral
N02BF02 [955152]
1.1e+00
1.3e+00
1.3e+00
—
1.3e+00
1.5e+00
1.0e+00
cases:7.82%
controls:2.87%
cases:5.20%
controls:1.53%
cases:1.67%
controls:0.48%
—
—
cases:1.87%
controls:0.52%
cases:6.42%
controls:1.48%
cases:8.74%
controls:3.39%
42
154
495
5216
28
82
510
5294
9
26
529
5350
—
10
28
526
5339
33
77
481
5119
39
152
407
4337
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
1.2e+00
1.2e+00
—
—
1.6e+00
1.2e+00
1.2e+00
cases:2.61%
controls:0.84%
cases:2.42%
controls:0.71%
—
—
—
—
cases:0.93%
controls:0.19%
cases:2.53%
controls:0.79%
cases:4.26%
controls:1.27%
14
45
523
5325
13
38
525
5338
—
—
5
10
531
5357
13
41
501
5155
19
57
427
4432
Other specified counselling
Z71.8 [45581061]
7.3e-01
5.2e-01
2.1e+00
—
2.0e+00
6.1e-01
4.9e-01
cases:6.70%
controls:3.35%
cases:3.16%
controls:1.90%
cases:1.67%
controls:0.20%
—
—
cases:1.31%
controls:0.19%
cases:3.89%
controls:2.16%
cases:10.09%
controls:6.42%
36
180
501
5190
17
102
521
5274
9
11
529
5365
—
7
10
529
5357
20
112
494
5084
45
288
401
4201
Bacteria identified in Isolate by Culture
43409-2 [3042936]
9.1e-01
1.1e+00
—
—
—
1.7e+00
9.6e-01
cases:5.03%
controls:2.09%
cases:2.60%
controls:0.86%
—
—
—
—
—
—
cases:3.70%
controls:0.67%
cases:6.28%
controls:2.49%
27
112
510
5258
14
46
524
5330
—
—
—
19
35
495
5161
28
112
418
4377
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.4e-01
1.5e-01
5.4e-01
3.1e+00
1.2e+00
4.3e-01
2.8e-01
cases:23.46%
controls:21.06%
cases:20.26%
controls:18.01%
cases:6.32%
controls:3.78%
cases:5.20%
controls:0.24%
cases:10.82%
controls:3.61%
cases:25.29%
controls:18.05%
cases:40.58%
controls:33.99%
126
1131
411
4239
109
968
429
4408
34
203
504
5173
28
13
510
5363
58
194
478
5173
130
938
384
4258
181
1526
265
2963
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.7e-01
4.5e-01
—
—
3.0e+00
1.0e+00
7.2e-01
cases:7.45%
controls:5.27%
cases:3.35%
controls:2.16%
—
—
—
—
cases:4.48%
controls:0.24%
cases:4.28%
controls:1.62%
cases:11.88%
controls:6.17%
40
283
497
5087
18
116
520
5260
—
—
24
13
512
5354
22
84
492
5112
53
277
393
4212
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.5e-01
4.5e-01
—
—
3.3e+00
7.6e-01
5.5e-01
cases:10.24%
controls:7.47%
cases:4.83%
controls:3.13%
—
—
—
—
cases:6.72%
controls:0.26%
cases:5.64%
controls:2.73%
cases:16.14%
controls:9.98%
55
401
482
4969
26
168
512
5208
—
—
36
14
500
5353
29
142
485
5054
72
448
374
4041
Laboratory Visit
OMOP4822461 [32036]
8.5e-02
9.9e-02
4.9e-01
3.2e+00
9.4e-01
1.3e-01
6.3e-02
cases:40.97%
controls:38.92%
cases:39.03%
controls:36.70%
cases:16.73%
controls:10.97%
cases:11.71%
controls:0.56%
cases:24.81%
controls:11.44%
cases:41.63%
controls:38.41%
cases:56.50%
controls:54.96%
220
2090
317
3280
210
1973
328
3403
90
590
448
4786
63
30
475
5346
133
614
403
4753
214
1996
300
3200
252
2467
194
2022
Office Visit
OMOP4822458 [581477]
6.1e-01
5.4e-01
1.8e+00
1.0e+50
2.4e+00
9.1e-01
6.6e-01
cases:13.78%
controls:8.03%
cases:4.46%
controls:2.64%
cases:1.12%
controls:0.19%
cases:1.30%
controls:0.00%
cases:3.36%
controls:0.32%
cases:5.45%
controls:2.27%
cases:11.43%
controls:6.26%
74
431
463
4939
24
142
514
5234
6
10
532
5366
7
0
531
5376
18
17
518
5350
28
118
486
5078
51
281
395
4208
magnesium hydroxide; oral
A02AA04 [21600052]
1.4e+00
2.4e+00
—
—
—
2.1e+00
1.3e+00
cases:1.30%
controls:0.32%
cases:1.49%
controls:0.13%
—
—
—
—
—
—
cases:1.36%
controls:0.17%
cases:1.57%
controls:0.42%
7
17
530
5353
8
7
530
5369
—
—
—
7
9
507
5187
7
19
439
4470
magnesium hydroxide; oral
G04BX01 [21602658]
1.4e+00
2.4e+00
—
—
—
2.1e+00
1.3e+00
cases:1.30%
controls:0.32%
cases:1.49%
controls:0.13%
—
—
—
—
—
—
cases:1.36%
controls:0.17%
cases:1.57%
controls:0.42%
7
17
530
5353
8
7
530
5369
—
—
—
7
9
507
5187
7
19
439
4470
Supplier / Service Provider
OMOP5117446 [33004]
-4.3e-01
-9.3e-01
—
—
—
2.7e+00
3.2e+00
cases:18.25%
controls:25.53%
cases:3.72%
controls:8.89%
—
—
—
—
—
—
cases:6.23%
controls:0.46%
cases:15.02%
controls:0.74%
98
1371
439
3999
20
478
518
4898
—
—
—
32
24
482
5172
67
33
379
4456
Nursing episode
950 [44777714]
3.5e-01
1.2e+00
1.1e+00
—
2.0e+00
1.2e+00
8.7e-01
cases:1.86%
controls:1.32%
cases:2.23%
controls:0.65%
cases:0.93%
controls:0.30%
—
—
cases:2.24%
controls:0.32%
cases:3.11%
controls:0.92%
cases:4.04%
controls:1.74%
10
71
527
5299
12
35
526
5341
5
16
533
5360
—
12
17
524
5350
16
48
498
5148
18
78
428
4411
Thorax X-ray examination
GD1AA [2001303617]
6.8e-01
6.1e-01
—
—
2.2e+00
7.3e-01
8.8e-01
cases:12.85%
controls:6.93%
cases:5.76%
controls:3.22%
—
—
—
—
cases:2.05%
controls:0.24%
cases:5.25%
controls:2.60%
cases:18.16%
controls:8.47%
69
372
468
4998
31
173
507
5203
—
—
11
13
525
5354
27
135
487
5061
81
380
365
4109
Orthopedic Surgery
20 [38004465]
4.8e-01
7.1e-01
1.1e+00
—
1.9e+00
7.2e-01
4.7e-01
cases:18.62%
controls:12.42%
cases:8.92%
controls:4.59%
cases:2.04%
controls:0.71%
—
—
cases:4.85%
controls:0.73%
cases:9.53%
controls:4.89%
cases:21.75%
controls:14.86%
100
667
437
4703
48
247
490
5129
11
38
527
5338
—
26
39
510
5328
49
254
465
4942
97
667
349
3822
furosemide; oral, parenteral
C03CA01 [21601518]
7.3e-01
9.1e-01
7.2e-01
—
1.1e+00
8.0e-01
6.4e-01
cases:9.31%
controls:4.69%
cases:9.11%
controls:3.89%
cases:2.60%
controls:1.28%
—
—
cases:3.17%
controls:1.06%
cases:8.75%
controls:4.14%
cases:12.78%
controls:7.15%
50
252
487
5118
49
209
489
5167
14
69
524
5307
—
17
57
519
5310
45
215
469
4981
57
321
389
4168
enoxaparin; parenteral
B01AB05 [21600976]
3.6e-01
-4.4e-01
—
—
2.9e+00
1.2e+00
2.8e-01
cases:5.96%
controls:4.25%
cases:0.93%
controls:1.43%
—
—
—
—
cases:2.99%
controls:0.17%
cases:2.92%
controls:0.89%
cases:5.16%
controls:3.94%
32
228
505
5142
5
77
533
5299
—
—
16
9
520
5358
15
46
499
5150
23
177
423
4312
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.9e-01
3.6e-01
5.8e-01
—
2.0e+00
9.9e-01
5.3e-01
cases:12.10%
controls:7.08%
cases:6.32%
controls:4.50%
cases:1.49%
controls:0.84%
—
—
cases:2.99%
controls:0.43%
cases:9.73%
controls:3.87%
cases:16.59%
controls:10.49%
65
380
472
4990
34
242
504
5134
8
45
530
5331
—
16
23
520
5344
50
201
464
4995
74
471
372
4018
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
6.1e-01
1.0e+00
—
—
2.5e+00
-2.6e-02
6.0e-01
cases:6.15%
controls:3.45%
cases:2.79%
controls:1.04%
—
—
—
—
cases:1.31%
controls:0.11%
cases:1.56%
controls:1.60%
cases:9.19%
controls:5.28%
33
185
504
5185
15
56
523
5320
—
—
7
6
529
5361
8
83
506
5113
41
237
405
4252
darbepoetin alfa; parenteral
B03XA02 [21601134]
—
—
—
—
—
2.1e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.17%
cases:1.57%
controls:0.22%
—
—
—
—
—
7
9
507
5187
7
10
439
4479
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.3e-01
-2.9e-01
6.0e-01
3.0e+00
1.0e+00
2.7e-01
2.8e-01
cases:9.50%
controls:7.71%
cases:5.20%
controls:6.81%
cases:2.97%
controls:1.66%
cases:1.86%
controls:0.09%
cases:3.54%
controls:1.30%
cases:8.75%
controls:6.85%
cases:16.59%
controls:13.03%
51
414
486
4956
28
366
510
5010
16
89
522
5287
10
5
528
5371
19
70
517
5297
45
356
469
4840
74
585
372
3904
oxycodone and naloxone; oral
N02AA55 [21604265]
2.3e-01
5.1e-01
—
—
2.7e+00
1.3e+00
2.4e-01
cases:2.05%
controls:1.64%
cases:0.93%
controls:0.56%
—
—
—
—
cases:1.31%
controls:0.09%
cases:2.14%
controls:0.60%
cases:3.81%
controls:3.03%
11
88
526
5282
5
30
533
5346
—
—
7
5
529
5362
11
31
503
5165
17
136
429
4353
gabapentin; oral
N02BF01 [955005]
9.2e-01
1.1e+00
1.6e+00
—
1.3e+00
9.8e-01
9.7e-01
cases:4.66%
controls:1.92%
cases:3.16%
controls:1.12%
cases:1.30%
controls:0.26%
—
—
cases:1.49%
controls:0.41%
cases:3.31%
controls:1.27%
cases:7.40%
controls:2.94%
25
103
512
5267
17
60
521
5316
7
14
531
5362
—
8
22
528
5345
17
66
497
5130
33
132
413
4357
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.8e-01
4.6e-01
—
—
3.2e+00
9.3e-01
6.7e-01
cases:5.59%
controls:3.52%
cases:2.23%
controls:1.41%
—
—
—
—
cases:3.17%
controls:0.13%
cases:2.72%
controls:1.10%
cases:8.97%
controls:4.81%
30
189
507
5181
12
76
526
5300
—
—
17
7
519
5360
14
57
500
5139
40
216
406
4273
Internal Medicine
11 [38004456]
4.8e-01
4.8e-01
7.9e-01
—
1.5e+00
6.9e-01
6.1e-01
cases:29.42%
controls:20.58%
cases:13.75%
controls:9.00%
cases:3.35%
controls:1.54%
—
—
cases:5.97%
controls:1.42%
cases:15.37%
controls:8.37%
cases:30.94%
controls:19.60%
158
1105
379
4265
74
484
464
4892
18
83
520
5293
—
32
76
504
5291
79
435
435
4761
138
880
308
3609
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.3e-01
2.2e-01
—
—
2.8e+00
8.7e-01
5.3e-01
cases:6.33%
controls:4.23%
cases:3.16%
controls:2.55%
—
—
—
—
cases:3.92%
controls:0.24%
cases:4.67%
controls:2.00%
cases:9.87%
controls:6.06%
34
227
503
5143
17
137
521
5239
—
—
21
13
515
5354
24
104
490
5092
44
272
402
4217
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
7.5e-01
—
—
—
—
2.5e+00
1.1e+00
cases:2.98%
controls:1.43%
—
—
—
—
—
—
—
—
cases:3.31%
controls:0.27%
cases:3.59%
controls:1.23%
16
77
521
5293
—
—
—
—
17
14
497
5182
16
55
430
4434
Vascular Surgery
77 [38004496]
5.2e-01
1.1e+00
—
—
1.5e+00
1.6e+00
8.7e-01
cases:3.35%
controls:2.03%
cases:2.97%
controls:0.99%
—
—
—
—
cases:1.12%
controls:0.26%
cases:4.09%
controls:0.85%
cases:6.73%
controls:2.94%
18
109
519
5261
16
53
522
5323
—
—
6
14
530
5353
21
44
493
5152
30
132
416
4357
Exposure to other specified factors
X58 [45756411]
7.0e-01
1.4e+00
—
1.0e+50
—
2.2e+00
6.6e-01
cases:3.35%
controls:1.69%
cases:2.42%
controls:0.60%
—
—
cases:7.62%
controls:0.00%
—
—
cases:3.11%
controls:0.37%
cases:3.59%
controls:1.89%
18
91
519
5279
13
32
525
5344
—
41
0
497
5376
—
16
19
498
5177
16
85
430
4404
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
6.8e-01
6.4e-01
—
—
2.7e+00
7.4e-01
9.1e-01
cases:2.79%
controls:1.43%
cases:1.30%
controls:0.69%
—
—
—
—
cases:1.87%
controls:0.13%
cases:1.56%
controls:0.75%
cases:4.26%
controls:1.76%
15
77
522
5293
7
37
531
5339
—
—
10
7
526
5360
8
39
506
5157
19
79
427
4410
Atherosclerosis of arteries of extremities
I70.2 [45538421]
1.0e+00
9.3e-01
1.4e+00
—
1.5e+00
1.1e+00
1.3e+00
cases:3.17%
controls:1.14%
cases:1.86%
controls:0.74%
cases:0.93%
controls:0.22%
—
—
cases:1.12%
controls:0.26%
cases:2.92%
controls:1.00%
cases:5.16%
controls:1.45%
17
61
520
5309
10
40
528
5336
5
12
533
5364
—
6
14
530
5353
15
52
499
5144
23
65
423
4424
Pharmacy visit
OMOP4822462 [581458]
3.7e-01
9.7e-02
5.0e-01
2.1e+00
8.3e-01
2.6e-01
2.3e-01
cases:94.79%
controls:92.63%
cases:82.90%
controls:81.47%
cases:55.02%
controls:42.52%
cases:15.99%
controls:2.27%
cases:63.25%
controls:42.80%
cases:85.41%
controls:81.85%
cases:95.74%
controls:94.72%
509
4974
28
396
446
4380
92
996
296
2286
242
3090
86
122
452
5254
339
2297
197
3070
439
4253
75
943
427
4252
19
237
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.0e+00
7.4e-01
—
—
1.4e+00
1.3e+00
1.1e+00
cases:2.98%
controls:1.08%
cases:2.04%
controls:0.99%
—
—
—
—
cases:0.93%
controls:0.22%
cases:3.11%
controls:0.87%
cases:5.16%
controls:1.78%
16
58
521
5312
11
53
527
5323
—
—
5
12
531
5355
16
45
498
5151
23
80
423
4409
Inpatient Visit
IP [9201]
4.0e-01
-1.7e-01
—
—
2.6e+00
8.6e-01
5.3e-01
cases:6.52%
controls:4.45%
cases:1.86%
controls:2.19%
—
—
—
—
cases:3.92%
controls:0.32%
cases:5.06%
controls:2.21%
cases:11.43%
controls:7.04%
35
239
502
5131
10
118
528
5258
—
—
21
17
515
5350
26
115
488
5081
51
316
395
4173
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
2.2e-01
1.9e-01
1.4e+00
—
1.9e+00
1.4e-01
3.0e-01
cases:39.29%
controls:34.15%
cases:18.59%
controls:15.89%
cases:6.69%
controls:1.67%
—
—
cases:11.94%
controls:1.94%
cases:17.12%
controls:15.26%
cases:41.26%
controls:34.19%
211
1834
326
3536
100
854
438
4522
36
90
502
5286
—
64
104
472
5263
88
793
426
4403
184
1535
262
2954
ibuprofen
R02AX02 [1588667]
2.2e-01
1.9e-01
1.4e+00
—
1.9e+00
1.4e-01
3.0e-01
cases:39.29%
controls:34.15%
cases:18.59%
controls:15.89%
cases:6.69%
controls:1.67%
—
—
cases:11.94%
controls:1.94%
cases:17.12%
controls:15.26%
cases:41.26%
controls:34.19%
211
1834
326
3536
100
854
438
4522
36
90
502
5286
—
64
104
472
5263
88
793
426
4403
184
1535
262
2954
Photocoagulation of retina
CKC12 [2001301394]
1.3e+00
2.1e+00
—
—
—
—
7.4e-01
cases:2.05%
controls:0.58%
cases:1.30%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.76%
11
31
526
5339
7
9
531
5367
—
—
—
—
7
34
439
4455
Handing over of treatment supplies
SPAT1262 [2001700363]
7.3e-01
9.6e-01
1.2e+00
—
1.2e+00
9.0e-01
6.8e-01
cases:7.08%
controls:3.54%
cases:5.39%
controls:2.14%
cases:1.30%
controls:0.41%
—
—
cases:1.49%
controls:0.47%
cases:5.45%
controls:2.29%
cases:8.74%
controls:4.63%
38
190
499
5180
29
115
509
5261
7
22
531
5354
—
8
25
528
5342
28
119
486
5077
39
208
407
4281
ABO and Rh group [Type] in Blood
882-1 [3003694]
2.2e-01
1.7e-01
—
—
3.2e+00
-2.4e-01
4.6e-01
cases:5.03%
controls:4.06%
cases:2.04%
controls:1.73%
—
—
—
—
cases:2.80%
controls:0.11%
cases:0.97%
controls:1.23%
cases:7.85%
controls:5.08%
27
218
510
5152
11
93
527
5283
—
—
15
6
521
5361
5
64
509
5132
35
228
411
4261
More than one and less than three hours
ZXE10 [2001311401]
3.7e-01
8.4e-01
2.2e+00
1.0e+50
—
2.6e-02
1.0e+00
cases:7.82%
controls:5.53%
cases:2.79%
controls:1.23%
cases:1.12%
controls:0.13%
cases:1.12%
controls:0.00%
—
—
cases:1.36%
controls:1.33%
cases:7.17%
controls:2.65%
42
297
495
5073
15
66
523
5310
6
7
532
5369
6
0
532
5376
—
7
69
507
5127
32
119
414
4370
Application of soft bandage
SPAT1211 [2001700312]
1.0e+00
7.0e-01
—
—
—
2.1e+00
5.7e-01
cases:2.61%
controls:0.95%
cases:0.93%
controls:0.47%
—
—
—
—
—
—
cases:1.56%
controls:0.19%
cases:1.79%
controls:1.02%
14
51
523
5319
5
25
533
5351
—
—
—
8
10
506
5186
8
46
438
4443
clindamycin; oral, parenteral
J01FF01 [21602985]
7.2e-01
6.3e-01
—
—
—
1.6e+00
8.3e-01
cases:6.52%
controls:3.28%
cases:2.04%
controls:1.10%
—
—
—
—
—
—
cases:4.47%
controls:0.98%
cases:6.73%
controls:3.05%
35
176
502
5194
11
59
527
5317
—
—
—
23
51
491
5145
30
137
416
4352
pH of Serum or Plasma
2753-2 [3018418]
6.0e-01
2.9e-01
7.6e-01
—
1.7e+00
7.5e-01
5.3e-01
cases:7.45%
controls:4.25%
cases:3.53%
controls:2.68%
cases:1.30%
controls:0.61%
—
—
cases:1.68%
controls:0.30%
cases:5.45%
controls:2.66%
cases:10.31%
controls:6.35%
40
228
497
5142
19
144
519
5232
7
33
531
5343
—
9
16
527
5351
28
138
486
5058
46
285
400
4204
Physiotherapist
Z3226 [2001311560]
1.4e-01
9.6e-01
—
—
—
1.7e+00
1.3e+00
cases:2.98%
controls:2.61%
cases:1.12%
controls:0.43%
—
—
—
—
—
—
cases:2.53%
controls:0.46%
cases:4.93%
controls:1.40%
16
140
521
5230
6
23
532
5353
—
—
—
13
24
501
5172
22
63
424
4426
Bacteria identified in Blood by Culture
600-7 [3023368]
6.8e-01
2.4e-01
1.5e+00
1.0e+50
2.3e+00
6.1e-01
4.1e-01
cases:7.08%
controls:3.72%
cases:2.79%
controls:2.21%
cases:1.12%
controls:0.26%
cases:1.67%
controls:0.00%
cases:2.61%
controls:0.26%
cases:3.31%
controls:1.83%
cases:8.74%
controls:5.97%
38
200
499
5170
15
119
523
5257
6
14
532
5362
9
0
529
5376
14
14
522
5353
17
95
497
5101
39
268
407
4221
Functional capacity evaluation
443351003 [40481051]
6.5e-01
7.0e-01
—
—
2.0e+00
9.6e-01
9.2e-01
cases:2.98%
controls:1.58%
cases:1.49%
controls:0.74%
—
—
—
—
cases:1.12%
controls:0.15%
cases:2.14%
controls:0.83%
cases:4.71%
controls:1.94%
16
85
521
5285
8
40
530
5336
—
—
6
8
530
5359
11
43
503
5153
21
87
425
4402
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.9e-01
3.4e-01
1.0e+00
—
2.0e+00
5.6e-01
4.6e-01
cases:15.64%
controls:10.19%
cases:8.18%
controls:5.93%
cases:1.67%
controls:0.60%
—
—
cases:4.48%
controls:0.65%
cases:8.17%
controls:4.85%
cases:23.32%
controls:16.13%
84
547
453
4823
44
319
494
5057
9
32
529
5344
—
24
35
512
5332
42
252
472
4944
104
724
342
3765
Acute cystitis
N30.0 [45601724]
5.6e-01
5.8e-01
—
—
—
1.8e+00
1.1e+00
cases:2.42%
controls:1.40%
cases:0.93%
controls:0.52%
—
—
—
—
—
—
cases:2.53%
controls:0.44%
cases:5.38%
controls:1.83%
13
75
524
5295
5
28
533
5348
—
—
—
13
23
501
5173
24
82
422
4407
Revision of wound of skin of lower limb
QDB05 [2001309969]
—
—
—
—
1.0e+50
—
2.8e+00
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.00%
—
—
cases:2.24%
controls:0.13%
—
—
—
—
12
0
524
5367
—
10
6
436
4483
Foot and toes X-ray examination
NH3AA [2001308267]
8.1e-01
1.1e+00
—
—
—
2.7e+00
7.1e-01
cases:1.49%
controls:0.67%
cases:0.93%
controls:0.32%
—
—
—
—
—
—
cases:1.75%
controls:0.12%
cases:2.02%
controls:1.00%
8
36
529
5334
5
17
533
5359
—
—
—
9
6
505
5190
9
45
437
4444
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
—
—
—
-1.0e+50
—
1.6e+00
cases:4.28%
controls:1.49%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.14%
controls:0.62%
23
80
514
5290
—
—
—
0
5
536
5362
—
14
28
432
4461
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
—
—
—
-1.0e+50
—
1.6e+00
cases:4.28%
controls:1.49%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.14%
controls:0.62%
23
80
514
5290
—
—
—
0
5
536
5362
—
14
28
432
4461
FEV1 percent change
69983-5 [42868472]
1.1e+00
—
—
—
-1.0e+50
—
1.6e+00
cases:4.28%
controls:1.49%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.14%
controls:0.62%
23
80
514
5290
—
—
—
0
5
536
5362
—
14
28
432
4461
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
—
—
—
-1.0e+50
—
1.6e+00
cases:4.28%
controls:1.49%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.14%
controls:0.62%
23
80
514
5290
—
—
—
0
5
536
5362
—
14
28
432
4461
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
—
—
—
-1.0e+50
—
1.6e+00
cases:4.28%
controls:1.49%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.14%
controls:0.62%
23
80
514
5290
—
—
—
0
5
536
5362
—
14
28
432
4461
Cathetrisation of vein
TPH04 [2001309597]
5.5e-01
1.9e-01
-1.0e+50
—
2.7e+00
6.0e-01
3.6e-01
cases:4.47%
controls:2.63%
cases:1.30%
controls:1.08%
cases:0.00%
controls:0.13%
—
—
cases:1.68%
controls:0.11%
cases:1.95%
controls:1.08%
cases:3.81%
controls:2.70%
24
141
513
5229
7
58
531
5318
0
7
538
5369
—
9
6
527
5361
10
56
504
5140
17
121
429
4368
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
4.5e-01
5.4e-01
—
—
1.8e+00
1.1e+00
8.8e-01
cases:2.42%
controls:1.56%
cases:1.49%
controls:0.87%
—
—
—
—
cases:1.49%
controls:0.24%
cases:2.14%
controls:0.73%
cases:4.26%
controls:1.80%
13
84
524
5286
8
47
530
5329
—
—
8
13
528
5354
11
38
503
5158
19
81
427
4408
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.3e-01
3.7e-01
6.2e-01
—
1.8e+00
8.6e-01
4.3e-01
cases:11.73%
controls:7.95%
cases:6.88%
controls:4.85%
cases:1.86%
controls:1.00%
—
—
cases:3.36%
controls:0.56%
cases:9.92%
controls:4.45%
cases:17.49%
controls:12.12%
63
427
474
4943
37
261
501
5115
10
54
528
5322
—
18
30
518
5337
51
231
463
4965
78
544
368
3945
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
8.2e-01
—
—
—
1.5e+00
5.8e-01
cases:2.98%
controls:0.97%
cases:1.30%
controls:0.58%
—
—
—
—
—
—
cases:1.75%
controls:0.40%
cases:3.59%
controls:2.05%
16
52
521
5318
7
31
531
5345
—
—
—
9
21
505
5175
16
92
430
4397
Diabetes non-insulin dependent
T90 [2002001131]
8.2e-01
7.8e-01
9.6e-01
—
1.1e+00
1.0e+00
4.4e-01
cases:9.31%
controls:4.34%
cases:5.76%
controls:2.73%
cases:1.12%
controls:0.43%
—
—
cases:1.12%
controls:0.39%
cases:7.78%
controls:3.02%
cases:9.42%
controls:6.28%
50
233
487
5137
31
147
507
5229
6
23
532
5353
—
6
21
530
5346
40
157
474
5039
42
282
404
4207
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
9.6e-01
2.2e-01
—
—
-1.0e+50
—
1.6e+00
cases:4.66%
controls:1.84%
cases:0.93%
controls:0.74%
—
—
—
—
cases:0.00%
controls:0.11%
—
—
cases:3.59%
controls:0.74%
25
99
512
5271
5
40
533
5336
—
—
0
6
536
5361
—
16
33
430
4456
FEV1
20150-9 [3024653]
9.6e-01
2.2e-01
—
—
-1.0e+50
—
1.6e+00
cases:4.66%
controls:1.84%
cases:0.93%
controls:0.74%
—
—
—
—
cases:0.00%
controls:0.11%
—
—
cases:3.59%
controls:0.74%
25
99
512
5271
5
40
533
5336
—
—
0
6
536
5361
—
16
33
430
4456
FEV1/FVC
19926-5 [3011505]
9.6e-01
2.2e-01
—
—
-1.0e+50
—
1.6e+00
cases:4.66%
controls:1.84%
cases:0.93%
controls:0.74%
—
—
—
—
cases:0.00%
controls:0.11%
—
—
cases:3.59%
controls:0.74%
25
99
512
5271
5
40
533
5336
—
—
0
6
536
5361
—
16
33
430
4456
Type 2 diabetes mellitus, with peripheral circulatory complications
E11.5 [45557114]
2.1e+00
—
—
—
—
—
2.6e+00
cases:0.93%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.18%
5
6
532
5364
—
—
—
—
—
10
8
436
4481
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.3e-01
4.0e-01
9.5e-01
—
5.3e-01
6.2e-01
5.2e-01
cases:20.48%
controls:14.38%
cases:12.27%
controls:8.58%
cases:4.09%
controls:1.62%
—
—
cases:2.80%
controls:1.66%
cases:14.20%
controls:8.16%
cases:26.01%
controls:17.35%
110
772
427
4598
66
461
472
4915
22
87
516
5289
—
15
89
521
5278
73
424
441
4772
116
779
330
3710
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.9e-01
2.4e-01
5.3e-01
—
1.1e+00
6.1e-01
4.2e-01
cases:21.60%
controls:15.70%
cases:13.01%
controls:10.53%
cases:3.72%
controls:2.23%
—
—
cases:5.60%
controls:1.98%
cases:17.70%
controls:10.49%
cases:31.39%
controls:23.06%
116
843
421
4527
70
566
468
4810
20
120
518
5256
—
30
106
506
5261
91
545
423
4651
140
1035
306
3454
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.4e-01
4.2e-01
6.6e-01
—
1.1e+00
5.2e-01
4.7e-01
cases:18.44%
controls:12.68%
cases:9.48%
controls:6.42%
cases:1.67%
controls:0.87%
—
—
cases:2.80%
controls:0.99%
cases:10.89%
controls:6.76%
cases:24.44%
controls:16.89%
99
681
438
4689
51
345
487
5031
9
47
529
5329
—
15
53
521
5314
56
351
458
4845
109
758
337
3731
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
8.0e-01
4.9e-01
—
—
—
1.6e+00
9.0e-01
cases:2.05%
controls:0.93%
cases:1.12%
controls:0.69%
—
—
—
—
—
—
cases:2.92%
controls:0.62%
cases:4.26%
controls:1.78%
11
50
526
5320
6
37
532
5339
—
—
—
15
32
499
5164
19
80
427
4409
General anaesthesia
WX402 [2001310806]
5.3e-01
2.8e-01
—
—
2.5e+00
5.7e-01
3.1e-01
cases:2.98%
controls:1.77%
cases:1.30%
controls:0.99%
—
—
—
—
cases:1.31%
controls:0.11%
cases:1.56%
controls:0.89%
cases:4.93%
controls:3.68%
16
95
521
5275
7
53
531
5323
—
—
7
6
529
5361
8
46
506
5150
22
165
424
4324
Implementation of podiatry rehabilitation plan
SPAT1225 [2001700326]
1.4e+00
2.5e+00
—
—
—
—
1.1e+00
cases:0.93%
controls:0.22%
cases:1.30%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.45%
5
12
532
5358
7
6
531
5370
—
—
—
—
6
20
440
4469
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
1.2e+00
2.4e+00
—
—
—
1.0e+00
1.1e+00
cases:1.68%
controls:0.52%
cases:1.49%
controls:0.13%
—
—
—
—
—
—
cases:0.97%
controls:0.35%
cases:2.24%
controls:0.78%
9
28
528
5342
8
7
530
5369
—
—
—
5
18
509
5178
10
35
436
4454
Limited function/disability NOS
A28 [2002000162]
-4.4e-02
3.0e-01
8.7e-01
—
1.5e+00
8.5e-01
8.5e-01
cases:1.68%
controls:1.75%
cases:1.30%
controls:0.97%
cases:0.93%
controls:0.39%
—
—
cases:1.87%
controls:0.41%
cases:2.53%
controls:1.10%
cases:5.83%
controls:2.58%
9
94
528
5276
7
52
531
5324
5
21
533
5355
—
10
22
526
5345
13
57
501
5139
26
116
420
4373
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
8.2e-01
1.0e+00
—
—
2.0e+00
1.5e+00
9.1e-01
cases:2.98%
controls:1.34%
cases:1.30%
controls:0.48%
—
—
—
—
cases:0.93%
controls:0.13%
cases:1.95%
controls:0.46%
cases:4.26%
controls:1.76%
16
72
521
5298
7
26
531
5350
—
—
5
7
531
5360
10
24
504
5172
19
79
427
4410
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.4e-01
4.3e-01
1.1e+00
1.0e+50
1.8e+00
4.6e-01
4.5e-01
cases:10.06%
controls:6.13%
cases:4.46%
controls:2.94%
cases:0.93%
controls:0.30%
cases:1.30%
controls:0.00%
cases:1.87%
controls:0.32%
cases:4.86%
controls:3.12%
cases:14.13%
controls:9.53%
54
329
483
5041
24
158
514
5218
5
16
533
5360
7
0
531
5376
10
17
526
5350
25
162
489
5034
63
428
383
4061
Teaching
WZC30 [2001310891]
2.8e-01
4.9e-01
—
—
2.3e+00
—
1.8e-01
cases:2.23%
controls:1.69%
cases:1.12%
controls:0.69%
—
—
—
—
cases:1.68%
controls:0.17%
—
—
cases:2.69%
controls:2.25%
12
91
525
5279
6
37
532
5339
—
—
9
9
527
5358
—
12
101
434
4388
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
—
2.3e+00
—
—
—
—
—
—
—
cases:1.30%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
7
7
531
5369
—
—
—
—
—
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
6.4e-01
1.2e+00
—
—
—
1.2e+00
5.0e-01
cases:3.35%
controls:1.79%
cases:3.35%
controls:1.08%
—
—
—
—
—
—
cases:3.11%
controls:1.00%
cases:5.16%
controls:3.19%
18
96
519
5274
18
58
520
5318
—
—
—
16
52
498
5144
23
143
423
4346
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.3e-01
3.7e-01
6.8e-01
—
2.3e+00
5.3e-01
3.6e-01
cases:10.80%
controls:7.30%
cases:6.32%
controls:4.45%
cases:1.67%
controls:0.86%
—
—
cases:4.10%
controls:0.43%
cases:7.00%
controls:4.25%
cases:15.02%
controls:10.98%
58
392
479
4978
34
239
504
5137
9
46
529
5330
—
22
23
514
5344
36
221
478
4975
67
493
379
3996
Other investigative procedure of eye
XCW99 [2001301491]
9.1e-01
1.4e+00
—
—
—
7.5e-01
6.6e-01
cases:3.54%
controls:1.45%
cases:2.04%
controls:0.52%
—
—
—
—
—
—
cases:0.97%
controls:0.46%
cases:2.47%
controls:1.29%
19
78
518
5292
11
28
527
5348
—
—
—
5
24
509
5172
11
58
435
4431
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.2e+00
9.6e-01
-1.0e+50
—
—
—
1.1e+00
cases:2.79%
controls:0.89%
cases:1.30%
controls:0.50%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:2.91%
controls:0.98%
15
48
522
5322
7
27
531
5349
0
6
538
5370
—
—
—
13
44
433
4445
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.3e-01
6.1e-03
—
—
1.7e+00
3.5e-01
1.3e-01
cases:9.68%
controls:5.94%
cases:2.79%
controls:2.77%
—
—
—
—
cases:1.87%
controls:0.34%
cases:4.28%
controls:3.04%
cases:9.87%
controls:8.78%
52
319
485
5051
15
149
523
5227
—
—
10
18
526
5349
22
158
492
5038
44
394
402
4095
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
7.8e-01
1.1e+00
—
—
—
1.1e+00
5.0e-01
cases:4.10%
controls:1.92%
cases:3.35%
controls:1.13%
—
—
—
—
—
—
cases:3.11%
controls:1.02%
cases:5.38%
controls:3.34%
22
103
515
5267
18
61
520
5315
—
—
—
16
53
498
5143
24
150
422
4339
Decubitus ulcer and pressure area
L89 [45601235]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.20%
—
—
—
—
—
—
8
9
438
4480
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
3.8e-01
—
—
—
—
2.2e+00
8.7e-01
cases:1.12%
controls:0.76%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.15%
cases:1.79%
controls:0.76%
6
41
531
5329
—
—
—
—
7
8
507
5188
8
34
438
4455
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.16%
—
—
—
—
—
—
6
7
440
4482
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.5e-01
5.8e-01
—
—
2.2e+00
8.8e-01
5.1e-01
cases:3.35%
controls:2.91%
cases:2.04%
controls:1.15%
—
—
—
—
cases:1.12%
controls:0.13%
cases:3.11%
controls:1.31%
cases:4.26%
controls:2.61%
18
156
519
5214
11
62
527
5314
—
—
6
7
530
5360
16
68
498
5128
19
117
427
4372
isosorbide mononitrate; oral
C01DA14 [21600324]
2.8e-01
5.0e-01
1.4e+00
—
3.3e-01
6.2e-01
7.3e-01
cases:3.54%
controls:2.70%
cases:3.53%
controls:2.18%
cases:2.04%
controls:0.50%
—
—
cases:0.93%
controls:0.67%
cases:4.09%
controls:2.23%
cases:6.05%
controls:3.01%
19
145
518
5225
19
117
519
5259
11
27
527
5349
—
5
36
531
5331
21
116
493
5080
27
135
419
4354
Emergency Room and Inpatient Visit
ERIP [262]
3.3e-01
1.1e-01
—
—
2.1e+00
5.5e-01
4.5e-01
cases:4.84%
controls:3.54%
cases:2.42%
controls:2.18%
—
—
—
—
cases:2.61%
controls:0.32%
cases:4.28%
controls:2.52%
cases:13.00%
controls:8.71%
26
190
511
5180
13
117
525
5259
—
—
14
17
522
5350
22
131
492
5065
58
391
388
4098
Foot/toe symptom/complaint
L17 [2002000641]
6.6e-01
7.2e-01
—
—
—
1.5e+00
6.1e-01
cases:6.52%
controls:3.48%
cases:2.79%
controls:1.38%
—
—
—
—
—
—
cases:4.09%
controls:0.98%
cases:7.85%
controls:4.41%
35
187
502
5183
15
74
523
5302
—
—
—
21
51
493
5145
35
198
411
4291
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.8e-01
2.7e-01
5.6e-01
—
1.1e+00
5.8e-01
2.9e-01
cases:21.79%
controls:16.00%
cases:10.97%
controls:8.61%
cases:2.23%
controls:1.28%
—
—
cases:2.99%
controls:0.97%
cases:14.20%
controls:8.49%
cases:26.23%
controls:21.07%
117
859
420
4511
59
463
479
4913
12
69
526
5307
—
16
52
520
5315
73
441
441
4755
117
946
329
3543
flucloxacillin; oral, parenteral
J01CF05 [21602857]
—
—
—
—
—
2.1e+00
7.6e-01
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.19%
cases:1.79%
controls:0.85%
—
—
—
—
—
8
10
506
5186
8
38
438
4451
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
3.6e-01
5.9e-01
7.0e-01
—
2.1e+00
4.4e-01
3.0e-01
cases:8.75%
controls:6.26%
cases:6.32%
controls:3.59%
cases:1.12%
controls:0.56%
—
—
cases:1.49%
controls:0.19%
cases:6.03%
controls:3.98%
cases:15.47%
controls:11.90%
47
336
490
5034
34
193
504
5183
6
30
532
5346
—
8
10
528
5357
31
207
483
4989
69
534
377
3955
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
6.4e-01
9.7e-01
—
—
—
1.1e+00
4.5e-01
cases:4.10%
controls:2.20%
cases:2.97%
controls:1.15%
—
—
—
—
—
—
cases:3.31%
controls:1.12%
cases:5.38%
controls:3.50%
22
118
515
5252
16
62
522
5314
—
—
—
17
58
497
5138
24
157
422
4332
Chronic kidney disease
N18 [45582391]
1.7e+00
—
—
—
—
—
2.0e+00
cases:0.93%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.18%
5
9
532
5361
—
—
—
—
—
6
8
440
4481
Amputation of toe
NHQ40 [2001308365]
—
—
—
1.0e+50
1.0e+50
—
2.0e+00
—
—
—
—
—
—
cases:0.93%
controls:0.00%
cases:1.12%
controls:0.00%
—
—
cases:1.35%
controls:0.18%
—
—
—
5
0
533
5376
6
0
530
5367
—
6
8
440
4481
Type 2 diabetes mellitus, with neurological complications
E11.4 [45576442]
2.0e+00
—
—
—
—
2.1e+00
1.2e+00
cases:1.68%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.12%
cases:1.35%
controls:0.40%
9
12
528
5358
—
—
—
—
5
6
509
5190
6
18
440
4471
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
2.0e+00
—
—
—
—
—
-1.0e+50
cases:1.12%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
6
8
531
5362
—
—
—
—
—
0
16
446
4473
Bloodpressure measurement
XF600 [2001303376]
—
2.0e+00
—
—
—
2.1e+00
1.1e+00
—
—
cases:1.12%
controls:0.15%
—
—
—
—
—
—
cases:0.97%
controls:0.12%
cases:2.02%
controls:0.69%
—
6
8
532
5368
—
—
—
5
6
509
5190
9
31
437
4458
Intravenous administration of medicine
SPAT1255 [2001700356]
9.9e-01
—
—
—
—
2.0e+00
8.9e-01
cases:1.49%
controls:0.56%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.21%
cases:1.35%
controls:0.56%
8
30
529
5340
—
—
—
—
8
11
506
5185
6
25
440
4464
Gas panel - Capillary blood
24337-8 [3022313]
6.8e-01
—
—
—
—
2.0e+00
8.4e-01
cases:1.49%
controls:0.76%
—
—
—
—
—
—
—
—
cases:1.75%
controls:0.25%
cases:2.24%
controls:0.98%
8
41
529
5329
—
—
—
—
9
13
505
5183
10
44
436
4445
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
—
2.0e+00
—
—
—
—
7.5e-01
—
—
cases:1.30%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.53%
—
7
10
531
5366
—
—
—
—
5
24
441
4465
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
—
2.0e+00
—
—
—
—
7.5e-01
—
—
cases:1.30%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.53%
—
7
10
531
5366
—
—
—
—
5
24
441
4465
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.6e-01
2.7e-01
5.5e-01
—
1.2e+00
7.3e-01
4.1e-01
cases:11.73%
controls:8.47%
cases:6.88%
controls:5.36%
cases:1.86%
controls:1.08%
—
—
cases:3.54%
controls:1.08%
cases:9.34%
controls:4.72%
cases:18.39%
controls:13.01%
63
455
474
4915
37
288
501
5088
10
58
528
5318
—
19
58
517
5309
48
245
466
4951
82
584
364
3905
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.1e+00
6.3e-01
—
—
—
5.6e-01
8.7e-01
cases:5.96%
controls:2.12%
cases:2.42%
controls:1.30%
—
—
—
—
—
—
cases:2.33%
controls:1.35%
cases:7.17%
controls:3.14%
32
114
505
5256
13
70
525
5306
—
—
—
12
70
502
5126
32
141
414
4348
Home Visit
OMOP4822459 [581476]
3.1e-01
2.6e-01
9.3e-01
—
1.4e+00
6.5e-01
5.7e-01
cases:5.77%
controls:4.30%
cases:3.35%
controls:2.60%
cases:2.42%
controls:0.97%
—
—
cases:3.73%
controls:0.99%
cases:5.64%
controls:3.02%
cases:11.43%
controls:6.82%
31
231
506
5139
18
140
520
5236
13
52
525
5324
—
20
53
516
5314
29
157
485
5039
51
306
395
4183
ferrous glycine sulfate; oral
B03AA01 [21601080]
9.3e-01
1.9e+00
—
—
—
1.7e+00
8.3e-01
cases:1.68%
controls:0.67%
cases:1.49%
controls:0.22%
—
—
—
—
—
—
cases:0.97%
controls:0.17%
cases:2.02%
controls:0.89%
9
36
528
5334
8
12
530
5364
—
—
—
5
9
509
5187
9
40
437
4449
Open wound of other parts of foot
S91.3 [45599027]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.25%
—
—
—
—
—
—
7
11
439
4478
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
4.6e-01
5.1e-01
—
—
—
1.2e+00
6.5e-01
cases:8.38%
controls:5.44%
cases:2.79%
controls:1.69%
—
—
—
—
—
—
cases:5.25%
controls:1.62%
cases:9.64%
controls:5.28%
45
292
492
5078
15
91
523
5285
—
—
—
27
84
487
5112
43
237
403
4252
Addiction caused by alcohol UNS
F10.29 [2000501684]
1.4e+00
—
—
—
—
-1.0e+50
1.8e+00
cases:1.12%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:1.79%
controls:0.29%
6
15
531
5355
—
—
—
—
0
5
514
5191
8
13
438
4476
Cutaneous abscess, furuncle and carbuncle of limb
L02.4 [45552967]
1.8e+00
—
—
—
—
—
—
cases:1.68%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
9
15
528
5355
—
—
—
—
—
—
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.8e+00
6.3e-01
—
—
—
1.2e+00
6.0e-01
cases:2.61%
controls:0.45%
cases:1.12%
controls:0.60%
—
—
—
—
—
—
cases:0.97%
controls:0.31%
cases:2.02%
controls:1.11%
14
24
523
5346
6
32
532
5344
—
—
—
5
16
509
5180
9
50
437
4439
Bipolar affective disorder, unspecified
F31.9 [45571758]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.27%
—
—
—
—
—
—
7
12
439
4477
ofloxacin; oral, parenteral
J01MA01 [21603008]
4.8e-01
—
—
—
—
—
1.8e+00
cases:0.93%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.31%
5
31
532
5339
—
—
—
—
—
8
14
438
4475
Endocrinology
46 [38004485]
4.6e-01
6.7e-01
8.9e-01
—
1.4e+00
1.0e+00
6.9e-01
cases:5.40%
controls:3.46%
cases:3.90%
controls:2.05%
cases:1.30%
controls:0.54%
—
—
cases:1.12%
controls:0.28%
cases:5.25%
controls:1.94%
cases:8.30%
controls:4.32%
29
186
508
5184
21
110
517
5266
7
29
531
5347
—
6
15
530
5352
27
101
487
5095
37
194
409
4295
Treatment-related counselling outside office
SPAT1249 [2001700350]
4.7e-01
5.2e-01
5.1e-01
—
1.7e+00
5.3e-01
4.7e-01
cases:11.17%
controls:7.32%
cases:4.83%
controls:2.94%
cases:0.93%
controls:0.56%
—
—
cases:2.05%
controls:0.37%
cases:4.67%
controls:2.81%
cases:12.33%
controls:8.09%
60
393
477
4977
26
158
512
5218
5
30
533
5346
—
11
20
525
5347
24
146
490
5050
55
363
391
4126
Social worker
Z2446 [2001311559]
4.1e-01
—
—
—
—
1.2e+00
1.7e+00
cases:1.12%
controls:0.74%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.29%
cases:3.14%
controls:0.58%
6
40
531
5330
—
—
—
—
5
15
509
5181
14
26
432
4463
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
—
—
—
—
—
1.7e+00
9.3e-01
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.29%
cases:1.79%
controls:0.71%
—
—
—
—
—
8
15
506
5181
8
32
438
4457
Contusion of lower back and pelvis
S30.0 [45549279]
1.7e+00
—
—
—
—
—
—
cases:1.49%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
529
5355
—
—
—
—
—
—
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
4.6e-01
3.8e-01
—
—
—
1.1e+00
5.8e-01
cases:7.26%
controls:4.69%
cases:3.35%
controls:2.31%
—
—
—
—
—
—
cases:5.06%
controls:1.81%
cases:10.31%
controls:6.06%
39
252
498
5118
18
124
520
5252
—
—
—
26
94
488
5102
46
272
400
4217
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
5.4e-01
5.1e-01
—
—
—
1.6e+00
5.9e-01
cases:1.68%
controls:0.99%
cases:0.93%
controls:0.56%
—
—
—
—
—
—
cases:1.95%
controls:0.38%
cases:2.47%
controls:1.38%
9
53
528
5317
5
30
533
5346
—
—
—
10
20
504
5176
11
62
435
4427
Type 1 diabetes mellitus, With renal complications
E10.2 [45586137]
1.6e+00
—
—
—
—
—
1.6e+00
cases:1.12%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.36%
6
12
531
5358
—
—
—
—
—
8
16
438
4473
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.6e+00
—
—
—
—
—
—
cases:1.49%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
529
5354
—
—
—
—
—
—
Sexual health counselling
SPAT1308 [2001700409]
1.1e-01
1.6e+00
—
—
—
—
6.4e-01
cases:1.49%
controls:1.34%
cases:1.49%
controls:0.30%
—
—
—
—
—
—
—
—
cases:2.91%
controls:1.56%
8
72
529
5298
8
16
530
5360
—
—
—
—
13
70
433
4419
Infiltration anesthesia
WX110 [2001310767]
2.1e-01
2.7e-01
6.0e-01
—
1.2e+00
3.5e-01
4.3e-01
cases:21.97%
controls:18.64%
cases:9.67%
controls:7.53%
cases:1.49%
controls:0.82%
—
—
cases:2.99%
controls:0.93%
cases:9.73%
controls:7.04%
cases:27.80%
controls:20.03%
118
1001
419
4369
52
405
486
4971
8
44
530
5332
—
16
50
520
5317
50
366
464
4830
124
899
322
3590
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
6.9e-01
—
—
—
—
—
1.6e+00
cases:2.05%
controls:1.04%
—
—
—
—
—
—
—
—
—
—
cases:4.93%
controls:1.05%
11
56
526
5314
—
—
—
—
—
22
47
424
4442
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
4.4e-01
2.2e-01
—
—
1.5e+00
4.5e-01
2.7e-01
cases:8.94%
controls:5.94%
cases:5.58%
controls:4.52%
—
—
—
—
cases:2.05%
controls:0.45%
cases:7.20%
controls:4.73%
cases:13.90%
controls:11.00%
48
319
489
5051
30
243
508
5133
—
—
11
24
525
5343
37
246
477
4950
62
494
384
3995
Constipation
K59.0 [45557663]
—
—
—
—
—
-1.0e+50
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:2.24%
controls:0.49%
—
—
—
—
—
0
5
514
5191
10
22
436
4467
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
8.5e-01
1.4e+00
—
—
-1.0e+50
1.5e+00
1.5e+00
cases:1.30%
controls:0.56%
cases:1.49%
controls:0.37%
—
—
—
—
cases:0.00%
controls:0.11%
cases:1.56%
controls:0.35%
cases:3.14%
controls:0.71%
7
30
530
5340
8
20
530
5356
—
—
0
6
536
5361
8
18
506
5178
14
32
432
4457
Intravenous general anesthesia
WX404 [2001310807]
2.0e-01
1.2e+00
—
—
—
1.1e+00
1.5e+00
cases:3.17%
controls:2.61%
cases:1.49%
controls:0.47%
—
—
—
—
—
—
cases:1.17%
controls:0.40%
cases:4.71%
controls:1.09%
17
140
520
5230
8
25
530
5351
—
—
—
6
21
508
5175
21
49
425
4440
Open wound of finger(s) without damage to nail
S61.0 [45578756]
1.5e+00
—
—
—
—
—
5.3e-01
cases:3.17%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:1.20%
17
39
520
5331
—
—
—
—
—
9
54
437
4435
nitrofurantoin; oral
J01XE01 [21603058]
3.3e-01
1.5e+00
-1.0e+50
—
—
4.6e-01
3.6e-01
cases:2.79%
controls:2.03%
cases:2.60%
controls:0.60%
cases:0.00%
controls:0.09%
—
—
—
—
cases:0.97%
controls:0.62%
cases:3.36%
controls:2.36%
15
109
522
5261
14
32
524
5344
0
5
538
5371
—
—
5
32
509
5164
15
106
431
4383
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
4.7e-01
1.4e-01
—
—
1.5e+00
4.5e-01
4.3e-01
cases:8.94%
controls:5.79%
cases:4.83%
controls:4.24%
—
—
—
—
cases:1.87%
controls:0.43%
cases:6.81%
controls:4.46%
cases:15.25%
controls:10.51%
48
311
489
5059
26
228
512
5148
—
—
10
23
526
5344
35
232
479
4964
68
472
378
4017
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
8.0e-01
7.9e-01
—
—
—
1.5e+00
4.7e-01
cases:3.91%
controls:1.79%
cases:1.67%
controls:0.76%
—
—
—
—
—
—
cases:2.33%
controls:0.54%
cases:3.81%
controls:2.41%
21
96
516
5274
9
41
529
5335
—
—
—
12
28
502
5168
17
108
429
4381
Sampling
SPAT1263 [2001700364]
1.6e-01
5.2e-01
1.5e+00
—
4.1e-01
6.4e-01
4.2e-01
cases:9.68%
controls:8.36%
cases:4.83%
controls:2.94%
cases:1.86%
controls:0.43%
—
—
cases:1.12%
controls:0.75%
cases:5.64%
controls:3.06%
cases:12.11%
controls:8.31%
52
449
485
4921
26
158
512
5218
10
23
528
5353
—
6
40
530
5327
29
159
485
5037
54
373
392
4116
pH of Capillary blood
2745-8 [3009343]
5.4e-01
6.0e-01
—
—
—
1.5e+00
5.1e-01
cases:1.68%
controls:0.99%
cases:1.12%
controls:0.61%
—
—
—
—
—
—
cases:2.14%
controls:0.50%
cases:2.69%
controls:1.63%
9
53
528
5317
6
33
532
5343
—
—
—
11
26
503
5170
12
73
434
4416
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
5.2e-01
5.7e-01
—
—
—
1.5e+00
5.0e-01
cases:1.68%
controls:1.01%
cases:1.12%
controls:0.63%
—
—
—
—
—
—
cases:2.14%
controls:0.50%
cases:2.69%
controls:1.65%
9
54
528
5316
6
34
532
5342
—
—
—
11
26
503
5170
12
74
434
4415
fenoterol and ipratropium bromide
R03AL01 [43534843]
5.7e-01
1.5e+00
—
—
—
1.1e+00
1.3e+00
cases:1.12%
controls:0.63%
cases:1.67%
controls:0.39%
—
—
—
—
—
—
cases:1.17%
controls:0.38%
cases:2.02%
controls:0.56%
6
34
531
5336
9
21
529
5355
—
—
—
6
20
508
5176
9
25
437
4464
Heart failure, unspecified
I50.9 [45576879]
8.2e-01
1.5e+00
—
—
—
7.4e-01
3.4e-01
cases:2.79%
controls:1.25%
cases:2.60%
controls:0.61%
—
—
—
—
—
—
cases:1.36%
controls:0.65%
cases:3.14%
controls:2.25%
15
67
522
5303
14
33
524
5343
—
—
—
7
34
507
5162
14
101
432
4388
Base excess in Venous blood by calculation
1927-3 [3002032]
1.5e+00
4.0e-01
—
—
—
1.1e+00
5.5e-01
cases:3.35%
controls:0.80%
cases:1.30%
controls:0.87%
—
—
—
—
—
—
cases:1.95%
controls:0.64%
cases:4.26%
controls:2.49%
18
43
519
5327
7
47
531
5329
—
—
—
10
33
504
5163
19
112
427
4377
lamotrigine; oral
N03AX09 [21604431]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.53%
—
—
—
—
—
—
10
24
436
4465
pH of Venous blood
2746-6 [3012544]
1.4e+00
3.8e-01
—
—
—
9.4e-01
5.0e-01
cases:3.54%
controls:0.86%
cases:1.30%
controls:0.89%
—
—
—
—
—
—
cases:1.75%
controls:0.69%
cases:4.26%
controls:2.63%
19
46
518
5324
7
48
531
5328
—
—
—
9
36
505
5160
19
118
427
4371
Right side
ZXA00 [2001311346]
5.5e-01
7.0e-01
—
—
—
1.4e+00
4.5e-01
cases:5.59%
controls:3.31%
cases:1.67%
controls:0.84%
—
—
—
—
—
—
cases:2.33%
controls:0.58%
cases:3.59%
controls:2.32%
30
178
507
5192
9
45
529
5331
—
—
—
12
30
502
5166
16
104
430
4385
Ophthalmology
18 [38004463]
2.6e-01
6.3e-01
1.6e-02
—
4.7e-01
7.7e-01
1.9e-01
cases:16.57%
controls:13.28%
cases:10.78%
controls:6.06%
cases:1.12%
controls:1.10%
—
—
cases:1.87%
controls:1.17%
cases:11.87%
controls:5.85%
cases:19.06%
controls:16.28%
89
713
448
4657
58
326
480
5050
6
59
532
5317
—
10
63
526
5304
61
304
453
4892
85
731
361
3758
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.4e+00
5.6e-01
1.7e+00
—
—
1.2e+00
5.9e-01
cases:3.17%
controls:0.80%
cases:1.49%
controls:0.86%
cases:0.93%
controls:0.17%
—
—
—
—
cases:1.95%
controls:0.62%
cases:4.48%
controls:2.54%
17
43
520
5327
8
46
530
5330
5
9
533
5367
—
—
10
32
504
5164
20
114
426
4375
Fracture of rib
S22.3 [45573285]
9.3e-01
—
—
—
—
—
1.4e+00
cases:1.49%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:3.59%
controls:0.91%
8
32
529
5338
—
—
—
—
—
16
41
430
4448
Removal of sutures
SPAT1153 [2001700254]
6.2e-01
7.4e-01
-1.0e+50
—
—
6.3e-01
7.6e-01
cases:8.57%
controls:4.80%
cases:2.23%
controls:1.08%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.33%
controls:1.25%
cases:7.62%
controls:3.72%
46
258
491
5112
12
58
526
5318
0
7
538
5369
—
—
12
65
502
5131
34
167
412
4322
Ultrasound measurement of residual urine
KC1EE [2001305918]
4.5e-01
5.1e-01
-1.0e+50
—
—
1.4e+00
4.0e-01
cases:2.61%
controls:1.68%
cases:1.12%
controls:0.67%
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.95%
controls:0.50%
cases:2.69%
controls:1.83%
14
90
523
5280
6
36
532
5340
0
7
538
5369
—
—
10
26
504
5170
12
82
434
4407
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
2.8e-01
8.9e-01
-1.0e+50
—
—
1.4e+00
4.1e-01
cases:1.30%
controls:0.99%
cases:1.49%
controls:0.61%
cases:0.00%
controls:0.09%
—
—
—
—
cases:2.14%
controls:0.56%
cases:2.91%
controls:1.96%
7
53
530
5317
8
33
530
5343
0
5
538
5371
—
—
11
29
503
5167
13
88
433
4401
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
2.2e-01
1.6e+00
—
—
—
1.5e+00
1.3e+00
cases:0.93%
controls:0.74%
cases:1.30%
controls:0.26%
—
—
—
—
—
—
cases:1.17%
controls:0.25%
cases:3.14%
controls:0.89%
5
40
532
5330
7
14
531
5362
—
—
—
6
13
508
5183
14
40
432
4449
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
7.6e-01
7.7e-01
1.4e+00
—
1.4e+00
1.3e+00
7.2e-01
cases:4.28%
controls:2.05%
cases:2.97%
controls:1.40%
cases:1.12%
controls:0.28%
—
—
cases:1.12%
controls:0.28%
cases:4.47%
controls:1.29%
cases:6.05%
controls:3.05%
23
110
514
5260
16
75
522
5301
6
15
532
5361
—
6
15
530
5352
23
67
491
5129
27
137
419
4352
Chronic rhinitis
J31.0 [45572165]
1.3e+00
—
—
—
—
—
—
cases:2.42%
controls:0.69%
—
—
—
—
—
—
—
—
—
—
—
—
13
37
524
5333
—
—
—
—
—
—
Administration of medicine
SPAT1254 [2001700355]
2.5e-01
1.2e+00
—
—
—
1.3e+00
6.2e-01
cases:2.42%
controls:1.90%
cases:1.86%
controls:0.60%
—
—
—
—
—
—
cases:2.33%
controls:0.67%
cases:3.59%
controls:1.96%
13
102
524
5268
10
32
528
5344
—
—
—
12
35
502
5161
16
88
430
4401
desogestrel
G03AC09 [21602505]
2.6e-01
—
—
—
—
7.4e-01
1.3e+00
cases:1.49%
controls:1.15%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.56%
cases:3.59%
controls:1.05%
8
62
529
5308
—
—
—
—
6
29
508
5167
16
47
430
4442
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
4.9e-01
6.2e-01
—
—
8.3e-01
6.2e-01
2.5e-01
cases:10.99%
controls:7.04%
cases:7.62%
controls:4.26%
—
—
—
—
cases:0.93%
controls:0.41%
cases:7.59%
controls:4.23%
cases:15.47%
controls:12.52%
59
378
478
4992
41
229
497
5147
—
—
5
22
531
5345
39
220
475
4976
69
562
377
3927
Abdominal ultrasound examination
JN3AE [2001305555]
8.6e-01
4.9e-01
—
—
—
1.2e+00
1.2e+00
cases:3.17%
controls:1.36%
cases:1.12%
controls:0.69%
—
—
—
—
—
—
cases:1.17%
controls:0.37%
cases:4.48%
controls:1.36%
17
73
520
5297
6
37
532
5339
—
—
—
6
19
508
5177
20
61
426
4428
calcium (different salts in combination); oral
A12AA20 [21600872]
3.8e-01
3.8e-01
1.3e-01
—
4.5e-01
6.4e-01
5.6e-01
cases:8.19%
controls:5.75%
cases:6.88%
controls:4.82%
cases:1.49%
controls:1.30%
—
—
cases:1.87%
controls:1.19%
cases:8.37%
controls:4.60%
cases:12.11%
controls:7.26%
44
309
493
5061
37
259
501
5117
8
70
530
5306
—
10
64
526
5303
43
239
471
4957
54
326
392
4163
Consultation of another employee
SPAT1260 [2001700361]
5.6e-01
1.2e+00
—
—
—
4.2e-01
8.3e-01
cases:4.10%
controls:2.38%
cases:2.42%
controls:0.76%
—
—
—
—
—
—
cases:1.17%
controls:0.77%
cases:4.71%
controls:2.12%
22
128
515
5242
13
41
525
5335
—
—
—
6
40
508
5156
21
95
425
4394
Erysipelas
A46 [45561706]
6.2e-01
6.3e-01
—
—
—
1.2e+00
7.2e-01
cases:3.17%
controls:1.73%
cases:1.12%
controls:0.60%
—
—
—
—
—
—
cases:2.53%
controls:0.81%
cases:3.81%
controls:1.89%
17
93
520
5277
6
32
532
5344
—
—
—
13
42
501
5154
17
85
429
4404
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
6.8e-02
1.7e-01
3.2e-01
—
8.0e-01
3.5e-01
2.4e-01
cases:31.10%
controls:29.66%
cases:26.39%
controls:23.21%
cases:5.58%
controls:4.13%
—
—
cases:8.77%
controls:4.16%
cases:29.18%
controls:22.42%
cases:48.88%
controls:43.02%
167
1593
370
3777
142
1248
396
4128
30
222
508
5154
—
47
223
489
5144
150
1165
364
4031
218
1931
228
2558
12 lead EKG panel
34534-8 [3044889]
2.3e-01
3.0e-01
1.3e-01
—
1.1e+00
4.1e-01
1.7e-01
cases:17.50%
controls:14.49%
cases:9.85%
controls:7.50%
cases:0.93%
controls:0.82%
—
—
cases:2.61%
controls:0.86%
cases:11.09%
controls:7.68%
cases:24.44%
controls:21.52%
94
778
443
4592
53
403
485
4973
5
44
533
5332
—
14
46
522
5321
57
399
457
4797
109
966
337
3523
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
8.8e-01
—
—
—
—
—
1.1e+00
cases:2.05%
controls:0.86%
—
—
—
—
—
—
—
—
—
—
cases:3.59%
controls:1.20%
11
46
526
5324
—
—
—
—
—
16
54
430
4435
One hour or less
ZXE00 [2001311394]
3.6e-01
6.3e-01
—
1.0e+50
—
7.2e-01
1.1e+00
cases:8.19%
controls:5.85%
cases:3.35%
controls:1.80%
—
—
cases:1.49%
controls:0.00%
—
—
cases:2.92%
controls:1.44%
cases:9.64%
controls:3.39%
44
314
493
5056
18
97
520
5279
—
8
0
530
5376
—
15
75
499
5121
43
152
403
4337
Pain localized to other parts of lower abdomen
R10.3 [45534426]
4.1e-01
5.6e-01
—
—
-1.0e+50
1.1e+00
6.9e-01
cases:3.72%
controls:2.50%
cases:1.30%
controls:0.74%
—
—
—
—
cases:0.00%
controls:0.15%
cases:2.53%
controls:0.87%
cases:4.93%
controls:2.54%
20
134
517
5236
7
40
531
5336
—
—
0
8
536
5359
13
45
501
5151
22
114
424
4375
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.1e+00
—
—
—
—
8.5e-01
5.4e-01
cases:2.79%
controls:0.97%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.50%
cases:3.59%
controls:2.12%
15
52
522
5318
—
—
—
—
6
26
508
5170
16
95
430
4394
digoxin; oral, parenteral
C01AA05 [21600234]
9.1e-01
1.1e+00
—
—
—
9.2e-01
5.5e-01
cases:2.61%
controls:1.06%
cases:2.42%
controls:0.84%
—
—
—
—
—
—
cases:2.14%
controls:0.87%
cases:1.79%
controls:1.05%
14
57
523
5313
13
45
525
5331
—
—
—
11
45
503
5151
8
47
438
4442
Scheduled procedure
ZXD10 [2001311387]
3.9e-01
7.3e-01
1.5e+00
—
—
7.1e-01
1.1e+00
cases:8.38%
controls:5.83%
cases:3.53%
controls:1.73%
cases:0.93%
controls:0.20%
—
—
—
—
cases:2.14%
controls:1.06%
cases:8.07%
controls:2.92%
45
313
492
5057
19
93
519
5283
5
11
533
5365
—
—
11
55
503
5141
36
131
410
4358
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.1e+00
4.2e-01
—
—
—
—
6.5e-01
cases:4.84%
controls:1.73%
cases:0.93%
controls:0.61%
—
—
—
—
—
—
—
—
cases:4.04%
controls:2.14%
26
93
511
5277
5
33
533
5343
—
—
—
—
18
96
428
4393
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
5.3e-01
1.1e+00
—
—
—
8.3e-01
2.3e-01
cases:5.59%
controls:3.37%
cases:3.35%
controls:1.19%
—
—
—
—
—
—
cases:2.92%
controls:1.29%
cases:5.61%
controls:4.50%
30
181
507
5189
18
64
520
5312
—
—
—
15
67
499
5129
25
202
421
4287
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
9.3e-01
7.6e-01
-1.0e+50
—
—
9.3e-01
1.0e+00
cases:2.61%
controls:1.04%
cases:1.30%
controls:0.61%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.17%
controls:0.46%
cases:3.59%
controls:1.31%
14
56
523
5314
7
33
531
5343
0
6
538
5370
—
—
6
24
508
5172
16
59
430
4430
temazepam; oral
N05CD07 [21604642]
2.2e-01
2.1e-01
4.8e-01
—
1.2e+00
6.6e-01
1.0e+00
cases:4.10%
controls:3.31%
cases:2.42%
controls:1.97%
cases:0.93%
controls:0.58%
—
—
cases:1.31%
controls:0.41%
cases:3.89%
controls:2.06%
cases:7.85%
controls:2.96%
22
178
515
5192
13
106
525
5270
5
31
533
5345
—
7
22
529
5345
20
107
494
5089
35
133
411
4356
Presence of intraocular lens
Z96.1 [45585885]
1.0e+00
7.4e-01
—
—
—
1.2e+00
5.9e-01
cases:2.79%
controls:1.02%
cases:0.93%
controls:0.45%
—
—
—
—
—
—
cases:1.56%
controls:0.46%
cases:3.14%
controls:1.76%
15
55
522
5315
5
24
533
5352
—
—
—
8
24
506
5172
14
79
432
4410
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
-1.6e-01
-6.2e-02
-1.0e+50
—
—
1.0e+00
5.4e-01
cases:3.72%
controls:4.36%
cases:1.49%
controls:1.58%
cases:0.00%
controls:0.43%
—
—
—
—
cases:4.28%
controls:1.60%
cases:6.95%
controls:4.19%
20
234
517
5136
8
85
530
5291
0
23
538
5353
—
—
22
83
492
5113
31
188
415
4301
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
1.5e-01
2.5e-01
5.8e-01
—
1.0e+00
3.7e-01
1.8e-01
cases:23.84%
controls:21.30%
cases:18.96%
controls:15.38%
cases:3.16%
controls:1.79%
—
—
cases:4.85%
controls:1.84%
cases:21.21%
controls:15.69%
cases:38.12%
controls:33.88%
128
1144
409
4226
102
827
436
4549
17
96
521
5280
—
26
99
510
5268
109
815
405
4381
170
1521
276
2968
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
4.2e-01
3.9e-01
—
—
—
9.9e-01
3.3e-01
cases:3.17%
controls:2.10%
cases:1.86%
controls:1.26%
—
—
—
—
—
—
cases:3.31%
controls:1.25%
cases:5.61%
controls:4.08%
17
113
520
5257
10
68
528
5308
—
—
—
17
65
497
5131
25
183
421
4306
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.7e-01
7.7e-02
5.7e-01
—
6.3e-01
3.8e-01
4.8e-01
cases:13.41%
controls:8.85%
cases:6.32%
controls:5.88%
cases:2.04%
controls:1.17%
—
—
cases:1.87%
controls:1.01%
cases:8.17%
controls:5.74%
cases:18.61%
controls:12.36%
72
475
465
4895
34
316
504
5060
11
63
527
5313
—
10
54
526
5313
42
298
472
4898
83
555
363
3934
hydroxyzine; oral, parenteral
N05BB01 [21604590]
2.1e-02
5.1e-01
—
—
—
1.3e+00
9.5e-01
cases:1.86%
controls:1.82%
cases:0.93%
controls:0.56%
—
—
—
—
—
—
cases:1.95%
controls:0.54%
cases:4.04%
controls:1.60%
10
98
527
5272
5
30
533
5346
—
—
—
10
28
504
5168
18
72
428
4417
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.6e-01
1.0e-01
5.5e-01
—
5.4e-01
4.0e-01
4.8e-01
cases:13.41%
controls:8.86%
cases:6.51%
controls:5.92%
cases:2.04%
controls:1.19%
—
—
cases:1.68%
controls:0.99%
cases:8.37%
controls:5.77%
cases:18.61%
controls:12.39%
72
476
465
4894
35
318
503
5058
11
64
527
5312
—
9
53
527
5314
43
300
471
4896
83
556
363
3933
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.7e-01
8.7e-02
6.6e-01
—
9.3e-01
4.5e-01
4.7e-01
cases:14.34%
controls:9.50%
cases:7.06%
controls:6.51%
cases:2.60%
controls:1.36%
—
—
cases:2.61%
controls:1.04%
cases:9.73%
controls:6.41%
cases:20.40%
controls:13.79%
77
510
460
4860
38
350
500
5026
14
73
524
5303
—
14
56
522
5311
50
333
464
4863
91
619
355
3870
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.1e-01
2.1e-01
1.9e-01
—
9.3e-01
3.5e-01
1.7e-01
cases:26.07%
controls:24.10%
cases:18.22%
controls:15.29%
cases:2.04%
controls:1.69%
—
—
cases:3.54%
controls:1.43%
cases:19.46%
controls:14.55%
cases:39.24%
controls:35.24%
140
1294
397
4076
98
822
440
4554
11
91
527
5285
—
19
77
517
5290
100
756
414
4440
175
1582
271
2907
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
9.2e-01
6.1e-01
—
—
—
3.7e-01
-2.2e-02
cases:3.54%
controls:1.43%
cases:1.86%
controls:1.02%
—
—
—
—
—
—
cases:1.36%
controls:0.94%
cases:1.57%
controls:1.60%
19
77
518
5293
10
55
528
5321
—
—
—
7
49
507
5147
7
72
439
4417
Gas panel - Venous blood
24339-4 [3000991]
9.3e-01
4.1e-01
—
—
—
1.3e+00
9.2e-01
cases:1.68%
controls:0.67%
cases:1.12%
controls:0.74%
—
—
—
—
—
—
cases:1.75%
controls:0.48%
cases:4.26%
controls:1.74%
9
36
528
5334
6
40
532
5336
—
—
—
9
25
505
5171
19
78
427
4411
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.0e-01
4.0e-01
5.2e-01
—
9.4e-01
5.2e-01
2.9e-01
cases:19.93%
controls:14.28%
cases:10.59%
controls:7.38%
cases:2.04%
controls:1.23%
—
—
cases:2.99%
controls:1.19%
cases:11.87%
controls:7.43%
cases:23.54%
controls:18.67%
107
767
430
4603
57
397
481
4979
11
66
527
5310
—
16
64
520
5303
61
386
453
4810
105
838
341
3651
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.6e-01
4.4e-02
5.7e-01
—
6.6e-01
3.9e-01
4.6e-01
cases:13.41%
controls:8.88%
cases:6.32%
controls:6.06%
cases:2.04%
controls:1.17%
—
—
cases:1.87%
controls:0.97%
cases:8.37%
controls:5.83%
cases:18.39%
controls:12.50%
72
477
465
4893
34
326
504
5050
11
63
527
5313
—
10
52
526
5315
43
303
471
4893
82
561
364
3928
Physical Medicine And Rehabilitation
25 [38004468]
4.9e-01
3.3e-01
—
—
1.2e+00
9.1e-01
4.3e-01
cases:9.12%
controls:5.77%
cases:2.97%
controls:2.16%
—
—
—
—
cases:1.31%
controls:0.41%
cases:5.06%
controls:2.10%
cases:10.09%
controls:6.79%
49
310
488
5060
16
116
522
5260
—
—
7
22
529
5345
26
109
488
5087
45
305
401
4184
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
3.3e-01
4.9e-01
—
—
-1.0e+50
—
9.1e-01
cases:1.49%
controls:1.08%
cases:1.12%
controls:0.69%
—
—
—
—
cases:0.00%
controls:0.24%
—
—
cases:4.93%
controls:2.05%
8
58
529
5312
6
37
532
5339
—
—
0
13
536
5354
—
22
92
424
4397
Diabetes, insulin-treated
103 [2001600103]
2.9e-01
—
—
—
—
—
9.0e-01
cases:3.91%
controls:2.96%
—
—
—
—
—
—
—
—
—
—
cases:4.71%
controls:1.96%
21
159
516
5211
—
—
—
—
—
21
88
425
4401
Left side
ZXA05 [2001311347]
1.5e-01
7.7e-01
—
—
—
1.0e+00
9.0e-01
cases:3.54%
controls:3.05%
cases:1.67%
controls:0.78%
—
—
—
—
—
—
cases:1.75%
controls:0.64%
cases:4.71%
controls:1.96%
19
164
518
5206
9
42
529
5334
—
—
—
9
33
505
5163
21
88
425
4401
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
8.9e-01
7.4e-02
-1.0e+50
—
—
8.9e-01
6.3e-01
cases:4.28%
controls:1.81%
cases:1.30%
controls:1.21%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.72%
controls:1.14%
cases:6.50%
controls:3.59%
23
97
514
5273
7
65
531
5311
0
7
538
5369
—
—
14
59
500
5137
29
161
417
4328
pH of Specimen
17433-4 [3019225]
1.5e-01
5.9e-01
—
—
—
1.2e+00
8.8e-01
cases:2.05%
controls:1.77%
cases:1.86%
controls:1.04%
—
—
—
—
—
—
cases:2.33%
controls:0.73%
cases:4.48%
controls:1.92%
11
95
526
5275
10
56
528
5320
—
—
—
12
38
502
5158
20
86
426
4403
Pain in limb
M79.6 [45587063]
5.3e-01
7.0e-01
—
—
1.4e+00
8.7e-01
2.9e-01
cases:8.57%
controls:5.21%
cases:4.46%
controls:2.27%
—
—
—
—
cases:1.12%
controls:0.28%
cases:5.25%
controls:2.27%
cases:10.54%
controls:8.11%
46
280
491
5090
24
122
514
5254
—
—
6
15
530
5352
27
118
487
5078
47
364
399
4125
insulin detemir; parenteral
A10AE05 [21600740]
8.6e-01
6.8e-01
—
—
—
7.2e-01
6.3e-01
cases:4.84%
controls:2.10%
cases:3.35%
controls:1.73%
—
—
—
—
—
—
cases:3.50%
controls:1.73%
cases:4.48%
controls:2.43%
26
113
511
5257
18
93
520
5283
—
—
—
18
90
496
5106
20
109
426
4380
Neurosurgery
14 [38004459]
1.4e-01
1.9e-01
-1.0e+50
—
—
6.3e-02
8.5e-01
cases:2.98%
controls:2.61%
cases:1.30%
controls:1.08%
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.17%
controls:1.10%
cases:5.38%
controls:2.38%
16
140
521
5230
7
58
531
5318
0
7
538
5369
—
—
6
57
508
5139
24
107
422
4382
Upper gastrointestinal surgery
106 [44777669]
2.5e-01
4.1e-01
—
—
-1.0e+50
7.8e-01
3.9e-01
cases:9.87%
controls:7.88%
cases:4.65%
controls:3.14%
—
—
—
—
cases:0.00%
controls:0.34%
cases:5.84%
controls:2.75%
cases:11.88%
controls:8.35%
53
423
484
4947
25
169
513
5207
—
—
0
18
536
5349
30
143
484
5053
53
375
393
4114
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.9e-01
4.7e-01
—
—
1.2e+00
7.8e-01
3.9e-01
cases:8.57%
controls:5.94%
cases:4.83%
controls:3.09%
—
—
—
—
cases:1.31%
controls:0.41%
cases:6.61%
controls:3.16%
cases:11.66%
controls:8.18%
46
319
491
5051
26
166
512
5210
—
—
7
22
529
5345
34
164
480
5032
52
367
394
4122
Urgent procedure
ZXD05 [2001311386]
1.6e-01
4.2e-01
—
1.0e+50
—
5.1e-01
7.6e-01
cases:4.47%
controls:3.84%
cases:1.86%
controls:1.23%
—
—
cases:1.67%
controls:0.00%
—
—
cases:1.75%
controls:1.06%
cases:6.05%
controls:2.92%
24
206
513
5164
10
66
528
5310
—
9
0
529
5376
—
9
55
505
5141
27
131
419
4358
Limited function/disability (L)
L28 [2002000647]
2.2e-01
5.5e-01
—
—
—
2.6e-01
7.6e-01
cases:2.05%
controls:1.66%
cases:1.67%
controls:0.97%
—
—
—
—
—
—
cases:1.17%
controls:0.90%
cases:5.61%
controls:2.70%
11
89
526
5281
9
52
529
5324
—
—
—
6
47
508
5149
25
121
421
4368
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
7.5e-01
2.3e-01
—
—
—
7.0e-01
5.4e-01
cases:4.84%
controls:2.35%
cases:1.67%
controls:1.34%
—
—
—
—
—
—
cases:2.33%
controls:1.17%
cases:4.26%
controls:2.52%
26
126
511
5244
9
72
529
5304
—
—
—
12
61
502
5135
19
113
427
4376
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.5e-01
4.0e-01
—
—
—
7.5e-01
4.1e-01
cases:7.08%
controls:5.10%
cases:3.90%
controls:2.66%
—
—
—
—
—
—
cases:5.84%
controls:2.85%
cases:10.76%
controls:7.44%
38
274
499
5096
21
143
517
5233
—
—
—
30
148
484
5048
48
334
398
4155
pH of Urine
2756-5 [3015736]
4.3e-01
3.8e-01
9.2e-01
—
7.7e-01
7.2e-01
3.1e-01
cases:9.68%
controls:6.50%
cases:5.02%
controls:3.48%
cases:1.30%
controls:0.52%
—
—
cases:1.12%
controls:0.52%
cases:7.00%
controls:3.52%
cases:14.35%
controls:10.98%
52
349
485
5021
27
187
511
5189
7
28
531
5348
—
6
28
530
5339
36
183
478
5013
64
493
382
3996
Rotator cuff syndrome
M75.1 [45596678]
7.2e-01
7.9e-01
-1.0e+50
—
—
4.3e-01
5.9e-01
cases:5.40%
controls:2.70%
cases:2.79%
controls:1.28%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.95%
controls:1.27%
cases:6.50%
controls:3.70%
29
145
508
5225
15
69
523
5307
0
8
538
5368
—
—
10
66
504
5130
29
166
417
4323
amitriptyline; oral, parenteral
N06AA09 [21604696]
4.8e-01
5.7e-01
1.3e+00
—
—
8.8e-01
7.2e-01
cases:4.66%
controls:2.94%
cases:2.60%
controls:1.49%
cases:0.93%
controls:0.26%
—
—
—
—
cases:3.31%
controls:1.40%
cases:6.28%
controls:3.16%
25
158
512
5212
14
80
524
5296
5
14
533
5362
—
—
17
73
497
5123
28
142
418
4347
Urology
34 [38004474]
4.8e-01
7.1e-01
—
—
8.4e-01
5.9e-01
2.9e-01
cases:8.57%
controls:5.49%
cases:6.32%
controls:3.20%
—
—
—
—
cases:1.12%
controls:0.48%
cases:4.86%
controls:2.75%
cases:9.19%
controls:7.06%
46
295
491
5075
34
172
504
5204
—
—
6
26
530
5341
25
143
489
5053
41
317
405
4172
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
3.3e-01
2.9e-01
7.0e-01
—
7.6e-01
7.1e-01
2.5e-01
cases:18.44%
controls:13.93%
cases:8.92%
controls:6.85%
cases:1.67%
controls:0.84%
—
—
cases:2.05%
controls:0.97%
cases:13.04%
controls:6.87%
cases:24.44%
controls:20.09%
99
748
438
4622
48
368
490
5008
9
45
529
5331
—
11
52
525
5315
67
357
447
4839
109
902
337
3587
mirtazapine; oral
N06AX11 [21604740]
3.8e-01
3.4e-01
8.2e-01
—
5.2e-01
7.1e-01
2.8e-01
cases:7.26%
controls:5.10%
cases:4.09%
controls:2.96%
cases:1.67%
controls:0.74%
—
—
cases:1.49%
controls:0.89%
cases:6.42%
controls:3.27%
cases:8.97%
controls:6.95%
39
274
498
5096
22
159
516
5217
9
40
529
5336
—
8
48
528
5319
33
170
481
5026
40
312
406
4177
Pain in joint
M25.5 [45586941]
7.0e-01
6.4e-01
—
—
—
3.6e-01
2.1e-01
cases:6.33%
controls:3.24%
cases:2.42%
controls:1.28%
—
—
—
—
—
—
cases:1.75%
controls:1.23%
cases:6.73%
controls:5.50%
34
174
503
5196
13
69
525
5307
—
—
—
9
64
505
5132
30
247
416
4242
Gastroenterology
10 [38004455]
2.0e-01
4.3e-01
—
—
—
5.9e-01
6.8e-01
cases:5.96%
controls:4.92%
cases:3.53%
controls:2.33%
—
—
—
—
—
—
cases:3.70%
controls:2.08%
cases:9.87%
controls:5.26%
32
264
505
5106
19
125
519
5251
—
—
—
19
108
495
5088
44
236
402
4253
enalapril; oral, parenteral
C09AA02 [21601786]
6.6e-01
4.4e-01
7.9e-01
—
-9.5e-02
6.5e-01
2.5e-01
cases:7.26%
controls:3.89%
cases:4.28%
controls:2.81%
cases:1.30%
controls:0.60%
—
—
cases:0.93%
controls:1.02%
cases:5.45%
controls:2.91%
cases:5.16%
controls:4.08%
39
209
498
5161
23
151
515
5225
7
32
531
5344
—
5
55
531
5312
28
151
486
5045
23
183
423
4306
piroxicam; ointment
M02AA07 [21604043]
6.5e-01
2.9e-01
—
—
—
1.3e+00
1.5e-01
cases:6.52%
controls:3.50%
cases:1.12%
controls:0.84%
—
—
—
—
—
—
cases:1.95%
controls:0.56%
cases:3.14%
controls:2.72%
35
188
502
5182
6
45
532
5331
—
—
—
10
29
504
5167
14
122
432
4367
Diabetes, non-insulin-treated
215 [2001600211]
6.4e-01
1.7e-01
—
—
—
2.2e-01
4.5e-01
cases:6.52%
controls:3.56%
cases:1.30%
controls:1.10%
—
—
—
—
—
—
cases:1.17%
controls:0.94%
cases:6.05%
controls:3.94%
35
191
502
5179
7
59
531
5317
—
—
—
6
49
508
5147
27
177
419
4312
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.7e-01
1.6e-01
5.0e-01
—
9.0e-01
3.7e-01
6.0e-01
cases:9.87%
controls:6.41%
cases:4.83%
controls:4.15%
cases:1.49%
controls:0.91%
—
—
cases:1.49%
controls:0.61%
cases:6.03%
controls:4.23%
cases:13.90%
controls:8.15%
53
344
484
5026
26
223
512
5153
8
49
530
5327
—
8
33
528
5334
31
220
483
4976
62
366
384
4123
prednisolone; oral, parenteral
H02AB06 [21602734]
1.4e-01
2.0e-01
3.0e-01
—
—
-9.8e-02
5.9e-01
cases:10.80%
controls:9.50%
cases:5.02%
controls:4.15%
cases:0.93%
controls:0.69%
—
—
—
—
cases:3.70%
controls:4.06%
cases:15.47%
controls:9.20%
58
510
479
4860
27
223
511
5153
5
37
533
5339
—
—
19
211
495
4985
69
413
377
4076
Type 2 diabetes mellitus
E11 [45571656]
5.9e-01
2.5e-01
—
—
—
6.1e-01
5.3e-01
cases:9.12%
controls:5.27%
cases:2.79%
controls:2.18%
—
—
—
—
—
—
cases:3.31%
controls:1.83%
cases:8.74%
controls:5.35%
49
283
488
5087
15
117
523
5259
—
—
—
17
95
497
5101
39
240
407
4249
prednisolone
A07EA01 [21600653]
1.4e-01
1.9e-01
3.0e-01
—
—
-4.4e-02
5.8e-01
cases:10.80%
controls:9.52%
cases:5.02%
controls:4.17%
cases:0.93%
controls:0.69%
—
—
—
—
cases:3.89%
controls:4.06%
cases:15.47%
controls:9.29%
58
511
479
4859
27
224
511
5152
5
37
533
5339
—
—
20
211
494
4985
69
417
377
4072
Comprehensive monitoring of chronic illness
SPAT1250 [2001700351]
5.8e-01
5.8e-01
—
—
—
6.2e-01
2.8e-01
cases:8.38%
controls:4.88%
cases:3.90%
controls:2.23%
—
—
—
—
—
—
cases:4.47%
controls:2.46%
cases:6.95%
controls:5.32%
45
262
492
5108
21
120
517
5256
—
—
—
23
128
491
5068
31
239
415
4250
zopiclone; oral
N05CF01 [21604654]
5.7e-01
2.7e-01
4.1e-01
—
1.1e-01
3.9e-01
4.8e-01
cases:10.61%
controls:6.29%
cases:5.20%
controls:4.04%
cases:1.67%
controls:1.12%
—
—
cases:1.49%
controls:1.34%
cases:5.64%
controls:3.91%
cases:10.31%
controls:6.66%
57
338
480
5032
28
217
510
5159
9
60
529
5316
—
8
72
528
5295
29
203
485
4993
46
299
400
4190
Essential (primary) hypertension
I10 [45591453]
3.7e-01
2.7e-01
3.8e-01
—
9.0e-01
5.2e-01
2.1e-01
cases:19.55%
controls:14.36%
cases:8.55%
controls:6.66%
cases:1.49%
controls:1.02%
—
—
cases:2.99%
controls:1.23%
cases:12.06%
controls:7.51%
cases:22.42%
controls:19.00%
105
771
432
4599
46
358
492
5018
8
55
530
5321
—
16
66
520
5301
62
390
452
4806
100
853
346
3636
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.4e-01
5.2e-02
5.5e-01
—
3.8e-01
3.2e-01
4.8e-01
cases:13.04%
controls:8.81%
cases:6.13%
controls:5.84%
cases:2.04%
controls:1.19%
—
—
cases:1.49%
controls:1.02%
cases:7.78%
controls:5.75%
cases:18.61%
controls:12.36%
70
473
467
4897
33
314
505
5062
11
64
527
5312
—
8
55
528
5312
40
299
474
4897
83
555
363
3934
Cardiology
6 [38004451]
3.0e-01
3.7e-01
—
—
7.0e-01
4.9e-01
4.8e-01
cases:11.17%
controls:8.53%
cases:6.32%
controls:4.46%
—
—
—
—
cases:1.49%
controls:0.75%
cases:6.61%
controls:4.18%
cases:15.25%
controls:10.00%
60
458
477
4912
34
240
504
5136
—
—
8
40
528
5327
34
217
480
4979
68
449
378
4040
metformin; oral
A10BA02 [21600747]
4.8e-01
2.6e-01
-4.1e-01
—
5.7e-01
4.3e-01
2.9e-01
cases:12.48%
controls:8.14%
cases:8.92%
controls:7.03%
cases:1.49%
controls:2.23%
—
—
cases:3.17%
controls:1.83%
cases:10.51%
controls:7.10%
cases:12.11%
controls:9.36%
67
437
470
4933
48
378
490
4998
8
120
530
5256
—
17
98
519
5269
54
369
460
4827
54
420
392
4069
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.2e-01
3.6e-02
5.6e-01
—
7.8e-01
4.7e-01
4.7e-01
cases:13.22%
controls:9.12%
cases:6.51%
controls:6.29%
cases:2.23%
controls:1.28%
—
—
cases:2.05%
controls:0.95%
cases:9.34%
controls:6.04%
cases:19.73%
controls:13.32%
71
490
466
4880
35
338
503
5038
12
69
526
5307
—
11
51
525
5316
48
314
466
4882
88
598
358
3891
Acute upper respiratory infection, unspecified
J06.9 [45562437]
3.3e-01
2.7e-01
—
—
6.2e-01
3.8e-01
4.7e-01
cases:10.06%
controls:7.47%
cases:4.46%
controls:3.44%
—
—
—
—
cases:0.93%
controls:0.50%
cases:5.06%
controls:3.52%
cases:16.37%
controls:10.94%
54
401
483
4969
24
185
514
5191
—
—
5
27
531
5340
26
183
488
5013
73
491
373
3998
Basophils [#/volume] in Blood
26444-0 [3006315]
4.3e-01
7.0e-02
5.6e-01
—
7.8e-01
4.7e-01
4.6e-01
cases:13.41%
controls:9.16%
cases:6.69%
controls:6.27%
cases:2.23%
controls:1.28%
—
—
cases:2.05%
controls:0.95%
cases:9.34%
controls:6.02%
cases:19.73%
controls:13.46%
72
492
465
4878
36
337
502
5039
12
69
526
5307
—
11
51
525
5316
48
313
466
4883
88
604
358
3885
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.2e-01
1.1e-01
4.4e-01
—
6.1e-01
3.6e-01
4.6e-01
cases:13.41%
controls:9.20%
cases:6.69%
controls:6.03%
cases:1.86%
controls:1.21%
—
—
cases:1.87%
controls:1.02%
cases:8.37%
controls:5.99%
cases:18.83%
controls:12.83%
72
494
465
4876
36
324
502
5052
10
65
528
5311
—
10
55
526
5312
43
311
471
4885
84
576
362
3913
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.3e-01
5.9e-02
5.5e-01
—
7.2e-01
4.7e-01
4.4e-01
cases:13.97%
controls:9.59%
cases:6.88%
controls:6.51%
cases:2.23%
controls:1.30%
—
—
cases:2.05%
controls:1.01%
cases:9.53%
controls:6.20%
cases:19.96%
controls:13.86%
75
515
462
4855
37
350
501
5026
12
70
526
5306
—
11
54
525
5313
49
322
465
4874
89
622
357
3867
Leukocytes [#/volume] in Synovial fluid
26469-7 [3000475]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
0
8
514
5188
—
itraconazole; oral, parenteral
J02AC02 [21603081]
4.9e-01
—
—
—
—
—
—
cases:2.05%
controls:1.27%
—
—
—
—
—
—
—
—
—
—
—
—
11
68
526
5302
—
—
—
—
—
—
Obstruction of bile duct
K83.1 [45548173]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
0
5
537
5365
0
6
538
5370
—
—
—
—
—
Ileoscopy through colon
UJF30 [2001305028]
6.1e-01
—
—
—
—
—
6.9e-01
cases:2.23%
controls:1.23%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:1.02%
12
66
525
5304
—
—
—
—
—
9
46
437
4443
Robot assisted procedure
ZXC96 [2001311382]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
0
7
446
4482
Timothy IgE Ab [Units/volume] in Serum
6265-3 [3003888]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
0
5
538
5371
—
—
—
0
9
514
5187
—
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
9.2e-01
1.1e-01
—
—
—
9.7e-01
4.5e-01
cases:3.17%
controls:1.28%
cases:0.93%
controls:0.84%
—
—
—
—
—
—
cases:1.36%
controls:0.52%
cases:3.36%
controls:2.16%
17
69
520
5301
5
45
533
5331
—
—
—
7
27
507
5169
15
97
431
4392
ERBB2 gene copy number/nucleus in Tissue by FISH
74860-8 [44816752]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
537
5365
—
—
—
—
—
—
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
3.4e-01
7.5e-01
-1.0e+50
—
—
4.8e-01
2.8e-01
cases:2.98%
controls:2.14%
cases:1.67%
controls:0.80%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.36%
controls:0.85%
cases:3.14%
controls:2.38%
16
115
521
5255
9
43
529
5333
0
8
538
5368
—
—
7
44
507
5152
14
107
432
4382
formoterol and budesonide
R03AK07 [21603281]
4.2e-01
—
—
—
—
—
1.6e-01
cases:2.42%
controls:1.60%
—
—
—
—
—
—
—
—
—
—
cases:2.69%
controls:2.29%
13
86
524
5284
—
—
—
—
—
12
103
434
4386
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
538
5371
—
—
—
—
—
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.1e-01
4.0e-01
7.5e-01
—
1.1e+00
4.3e-01
3.2e-01
cases:11.55%
controls:8.01%
cases:6.69%
controls:4.59%
cases:1.49%
controls:0.71%
—
—
cases:1.87%
controls:0.63%
cases:7.78%
controls:5.20%
cases:18.83%
controls:14.44%
62
430
475
4940
36
247
502
5129
8
38
530
5338
—
10
34
526
5333
40
270
474
4926
84
648
362
3841
Short time oxymetry
XG460 [2001303865]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
0
6
537
5364
—
—
—
—
—
0
7
446
4482
long-acting sulfonamides - combinations
J01ED20 [21602959]
5.1e-01
—
—
—
—
1.3e+00
6.8e-01
cases:2.61%
controls:1.58%
—
—
—
—
—
—
—
—
cases:1.17%
controls:0.31%
cases:1.57%
controls:0.80%
14
85
523
5285
—
—
—
—
6
16
508
5180
7
36
439
4453
Dentistry
C5 [903277]
-1.3e-01
3.1e-01
-1.0e+50
—
-1.0e+50
7.7e-01
1.7e-01
cases:1.86%
controls:2.12%
cases:1.12%
controls:0.82%
cases:0.00%
controls:0.11%
—
—
cases:0.00%
controls:0.15%
cases:1.36%
controls:0.64%
cases:2.47%
controls:2.09%
10
114
527
5256
6
44
532
5332
0
6
538
5370
—
0
8
536
5359
7
33
507
5163
11
94
435
4395
glibenclamide; oral
A10BB01 [21600750]
—
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.38%
—
—
0
5
538
5371
—
—
—
0
17
446
4472
Acute myocardial infarction, unspecified
I21.9 [45605780]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
446
4484
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
0
9
537
5361
0
5
538
5371
—
—
—
0
7
514
5189
—
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
—
—
—
—
—
—
9.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.60%
—
—
—
—
—
—
7
27
439
4462
Sprain and strain of other and unspecified parts of hand
S63.7 [45607996]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
446
4484
brimonidine
S01GA07 [947915]
1.2e+00
—
—
—
—
1.6e+00
1.3e+00
cases:0.93%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.19%
cases:1.35%
controls:0.38%
5
15
532
5355
—
—
—
—
5
10
509
5186
6
17
440
4472
ambroxol
R02AD05 [954864]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
537
5357
—
—
—
—
—
—
Skin texture symptom/complaint
S21 [2002000986]
-3.7e-01
—
—
—
—
1.1e+00
6.1e-01
cases:0.93%
controls:1.34%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.46%
cases:2.91%
controls:1.60%
5
72
532
5298
—
—
—
—
7
24
507
5172
13
72
433
4417
Excision of burn of lower limb and coverage
QDD20 [2001309977]
—
—
—
1.0e+50
1.0e+50
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.00%
cases:9.51%
controls:0.00%
—
—
—
—
—
—
—
31
0
507
5376
51
0
485
5367
—
—
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
X49 [45756405]
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.00%
—
—
—
—
—
—
—
—
5
0
531
5367
—
—
Second degree perineal laceration during delivery
O70.1 [45572890]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
0
11
537
5359
—
—
—
—
—
0
7
446
4482
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
1.1e-01
3.4e-01
—
—
—
—
7.3e-01
cases:3.17%
controls:2.85%
cases:1.12%
controls:0.80%
—
—
—
—
—
—
—
—
cases:4.48%
controls:2.21%
17
153
520
5217
6
43
532
5333
—
—
—
—
20
99
426
4390
Acute otitis media/myringitis
H71 [2002000526]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
537
5365
—
—
—
—
—
—
Cellulitis of external ear
H60.1 [45547946]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
537
5361
—
—
—
—
—
—
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
7.4e-01
8.4e-01
—
—
—
5.5e-01
4.2e-01
cases:3.54%
controls:1.71%
cases:2.04%
controls:0.89%
—
—
—
—
—
—
cases:1.56%
controls:0.90%
cases:3.59%
controls:2.38%
19
92
518
5278
11
48
527
5328
—
—
—
8
47
506
5149
16
107
430
4382
Early examination of pregnancy
XMA20 [2001306915]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
537
5365
—
—
—
—
—
—
Hand and fingers extensive X-ray examination
ND2BA [2001307610]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
0
10
446
4479
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
4.2e-01
3.0e-01
1.3e+00
—
1.2e+00
4.0e-01
3.2e-01
cases:5.59%
controls:3.72%
cases:2.97%
controls:2.21%
cases:1.67%
controls:0.47%
—
—
cases:1.31%
controls:0.39%
cases:3.89%
controls:2.64%
cases:7.85%
controls:5.84%
30
200
507
5170
16
119
522
5257
9
25
529
5351
—
7
21
529
5346
20
137
494
5059
35
262
411
4227

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
120
580
2.36
14.23
2.6
1.7
—
—
—
0
0
61
288
2.26
7.46
2.1
2.5
—
—
—
0
0
268
2040
1.61
6.93
9.7
7.1
1.21
1.21
mmol/l
0.30
256
1897
187
1305
1.65
6.87
6.5
4.5
—
—
—
0
0
128
810
1.75
6.73
3.8
3.7
0.80
0.82
mmol/l
0.69
121
771
261
1991
1.59
6.58
6.5
5.6
35.19
36.13
g/l
1.57
247
1886
117
728
1.77
6.51
4.1
2.1
—
—
—
0
0
219
1607
1.60
6.48
6.6
6.7
—
—
—
0
0
271
2106
1.56
6.18
16.5
13.3
1.26
1.22
inr
0.53
231
1750
67
356
2.00
6.06
2.2
2.8
65.17
67.08
g/l
1.08
59
334
109
683
1.74
5.88
1.7
1.6
1318.84
1166.73
nmol/l
0.77
85
533
170
1198
1.60
5.84
2.5
2.3
3.32
2.90
mg/l
1.19
143
1050
173
1225
1.60
5.83
3.6
3.1
—
—
—
0
0
336
2768
1.54
5.70
7.4
5.5
6.98
6.66
mmol/l
1.91
323
2628
183
1332
1.56
5.41
6.1
4.2
7.40
7.40
ph
0.02
131
957
304
2471
1.51
5.34
6.7
6.6
0.61
0.59
e9/l
0.92
271
2131
304
2475
1.51
5.27
6.7
6.7
0.04
0.04
e9/l
0.30
270
2136
352
2956
1.52
5.25
6.1
4.4
566.86
131.02
e6/l
—
7
45
408
3543
1.58
5.19
9.8
8.5
80.95
79.94
u/l
0.18
393
3366
55
291
1.99
5.04
6.3
4.3
24.43
24.24
mmol/l
0.14
55
291
310
2551
1.49
4.99
7.8
7.0
0.20
0.19
e9/l
0.32
284
2245
193
1442
1.52
4.99
2.6
2.2
198.44
268.07
u/l
0.53
183
1382
82
496
1.77
4.97
6.7
4.3
7.36
7.38
ph
1.42
56
295
307
2525
1.48
4.93
6.7
6.7
1.79
1.90
e9/l
1.41
279
2238
86
529
1.74
4.92
3.0
3.0
1.81
1.77
%
0.14
80
482
328
2737
1.49
4.88
10.8
10.3
4.37
4.11
e9/l
1.09
291
2380
280
2267
1.48
4.83
10.8
7.8
1.20
1.21
mmol/l
0.55
247
1996
78
472
1.76
4.72
7.1
4.3
1.63
1.83
mmol/l
0.16
72
408
164
1197
1.53
4.68
5.2
4.4
89.13
89.88
%
0.14
157
1181
100
653
1.65
4.58
10.5
6.4
1.14
1.03
mmol/l
2.69
95
612
168
1239
1.51
4.55
3.0
2.9
357.45
350.24
umol/l
0.40
145
1108
299
2471
1.46
4.53
7.2
7.0
11.84
11.86
umol/l
0.00
292
2359
228
1790
1.47
4.52
4.7
3.7
40.03
43.66
ng/l
0.14
170
1252
79
490
1.71
4.38
7.0
4.2
5.88
5.81
kpa
0.30
79
480
211
1640
1.46
4.37
4.5
3.3
7.49
8.36
mmol/l
1.87
183
1410
280
2297
1.44
4.35
7.3
6.8
8.91
8.90
%
0.02
269
2173
279
2288
1.44
4.33
7.2
6.8
0.67
0.68
%
0.16
268
2158
279
2291
1.44
4.29
7.1
6.7
2.95
2.89
%
0.18
268
2164
247
1984
1.44
4.27
2.2
2.0
91.43
96.23
pmol/l
1.05
156
1076
285
2355
1.43
4.20
7.0
6.7
26.96
27.83
%
0.70
277
2251
386
3376
1.47
4.18
4.4
3.5
59.82
49.24
u/l
1.04
371
3217
281
2328
1.42
4.02
7.0
6.6
58.54
57.03
%
1.40
273
2234
169
1286
1.45
3.82
1.7
1.7
19.33
20.20
nmol/l
0.35
145
1100
269
2228
1.40
3.77
3.6
3.0
113.12
130.22
ug/l
0.91
248
2098
66
407
1.71
3.75
3.6
2.9
69.92
70.37
e9/l
0.03
53
294
183
1418
1.43
3.74
7.3
6.6
—
—
—
0
0
23
97
2.43
3.70
1.7
1.7
—
—
—
0
0
145
1078
1.47
3.68
1.7
1.4
2.43
2.52
g/l
0.24
96
677
30
144
2.15
3.60
1.2
1.2
—
—
—
0
0
263
2186
1.39
3.54
3.7
2.8
—
—
estimate
—
0
0
47
268
1.82
3.49
1.4
1.2
—
—
—
0
0
66
417
1.66
3.43
4.4
3.6
4.91
4.52
kpa
0.43
66
407
186
1470
1.40
3.33
4.2
3.4
94.66
56.92
mg/l
0.92
125
991
13
38
3.48
3.33
1.2
1.1
—
—
—
0
0
245
2027
1.37
3.33
2.8
2.5
74.07
74.12
nmol/l
0.01
222
1833
210
1697
1.38
3.29
3.4
3.5
34.45
34.06
u/l
0.04
200
1617
194
1552
1.38
3.21
3.4
2.5
—
—
—
0
0
12
34
3.58
3.21
2.6
3.3
1270.00
579.88
mg
0.96
12
34
33
173
1.96
3.16
2.4
4.5
479.93
316.65
mg/l
0.45
14
84
85
583
1.54
3.16
3.7
3.1
9.16
8.74
umol/l
0.05
75
531
173
1362
1.39
3.14
4.5
3.7
0.00
0.01
estimate
0.96
56
467
291
2493
1.35
3.09
4.3
3.7
43.61
6.04
estimate
0.64
61
502
51
310
1.71
3.07
6.9
4.3
88.11
83.50
ng/l
0.16
42
275
110
801
1.47
3.07
3.8
2.5
12.43
13.79
umol/l
1.29
104
754
167
1312
1.39
3.06
3.4
3.3
2637.49
1126.91
ng/l
1.63
142
1115
153
1187
1.40
3.02
1.5
1.3
1.35
1.64
u/ml
0.21
42
334
106
769
1.47
3.01
3.8
3.1
2.33
1.76
e6/l
0.41
64
378
186
1492
1.37
3.00
5.1
4.1
15.97
9.46
mg/mmol
0.95
122
979
291
2508
1.34
2.90
4.4
3.7
0.00
0.65
estimate
0.50
56
465
65
429
1.58
2.86
2.2
2.1
0.00
0.03
estimate
0.50
16
103
286
2470
1.33
2.76
4.3
3.6
0.00
0.00
estimate
-0.00
56
496
136
1049
1.39
2.75
4.0
2.6
6.81
4.86
e6/l
0.82
126
951
66
443
1.56
2.71
11.4
9.9
—
—
—
0
0
11
35
3.19
2.65
1.1
3.0
—
—
—
0
0
29
156
1.91
2.62
2.5
3.4
38.00
44.48
mg/l
0.20
24
134
29
156
1.91
2.62
2.5
3.4
63.77
88.57
mg/l
0.27
23
133
185
1513
1.33
2.56
2.7
3.5
2.35
2.35
mmol/l
0.03
170
1386
461
4302
1.43
2.52
7.7
6.1
40.46
39.16
mmol/mol
1.89
432
4079
187
1536
1.33
2.50
5.0
3.3
251.05
52.41
e6/l
0.48
153
1157
13
51
2.59
2.46
1.8
2.2
1.50
1.43
g/24h
—
6
37
235
1998
1.31
2.45
3.8
3.3
6.23
6.19
ph
0.27
126
1150
182
1495
1.32
2.43
3.9
2.7
51.32
66.23
u/l
2.66
175
1405
118
910
1.38
2.37
3.5
3.0
525.89
552.42
mosm/kgh2o
0.66
108
794
10
33
3.07
2.36
2.1
4.1
10.84
8.48
mmol/l
—
10
33
44
279
1.63
2.31
2.1
1.8
—
—
—
0
0
22
114
1.97
2.23
2.0
2.5
97.50
83.21
ug/min
0.18
14
72
44
282
1.61
2.22
2.1
1.7
—
—
—
0
0
114
885
1.36
2.20
1.8
1.7
76042110.78
29708654.41
pmol/l
0.26
96
754
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
44
284
1.60
2.16
2.1
1.8
—
—
—
0
0
162
1328
1.31
2.16
4.7
3.2
0.33
0.36
e6/l
0.13
129
962
487
4620
1.45
2.14
24.9
15.5
23.59
24.05
mg/l
0.12
416
3759
76
554
1.43
2.12
9.3
9.7
1.35
0.84
mmol/l
0.56
62
470
32
192
1.71
2.08
12.0
2.0
—
—
—
0
0
83
617
1.41
2.08
1.5
1.5
—
—
—
0
0
24
133
1.84
2.02
1.2
1.4
277.15
295.97
ug/g
0.12
13
76
221
1901
1.27
2.01
4.0
3.5
0.06
0.01
estimate
0.37
49
418
205
1748
1.27
2.00
5.7
3.9
76.01
82.60
e6/l
0.07
156
1228
135
1093
1.31
1.96
4.3
3.6
—
0.20
—
0
10
29
174
1.70
1.90
1.6
1.7
3.64
9.26
u/ml
—
5
39
23
130
1.80
1.84
2.8
2.1
—
—
—
0
0
134
1094
1.30
1.82
1.8
1.8
1.22
1.42
mg/l
0.40
102
852
6
18
3.36
1.75
1.0
2.1
—
—
—
0
0
243
2147
1.23
1.67
14.4
11.3
0.00
0.00
e9/l
0.80
198
1751
39
262
1.53
1.66
2.2
1.8
—
—
—
0
0
79
607
1.35
1.64
1.2
1.2
—
—
—
0
0
63
467
1.39
1.63
2.4
2.5
33.15
36.82
u/l
0.30
53
396
24
144
1.70
1.60
2.5
3.2
1.35
2.68
ratio
1.25
15
82
6
20
3.02
1.58
1.2
1.2
108.67
181.98
mmol/24h
—
6
20
177
1522
1.24
1.55
3.6
3.5
—
0.60
—
0
5
62
463
1.38
1.54
8.5
8.6
1.34
1.38
mmol/l
0.11
62
456
9
182
0.49
1.53
2.1
2.5
85.14
48.29
u/ml
—
9
177
487
4671
1.35
1.53
27.8
18.1
4.00
3.97
mmol/l
1.45
480
4591
50
361
1.42
1.51
3.2
2.1
5.98
6.08
ph
0.31
32
241
6
21
2.88
1.51
1.5
1.5
—
—
—
0
0
73
563
1.34
1.49
9.5
9.7
7.41
7.42
ph
0.30
46
314
486
4667
1.34
1.45
27.4
17.9
139.40
139.67
mmol/l
1.91
480
4595
5
16
3.14
1.44
1.2
1.3
—
—
—
0
0
36
247
1.49
1.41
2.1
2.1
0.00
2.82
estimate
0.50
13
89
41
289
1.45
1.41
9.9
8.7
24.50
24.36
mmol/l
0.09
41
273
445
4229
1.27
1.41
5.7
4.9
1.88
1.90
mu/l
0.14
411
3934
132
1110
1.25
1.40
5.2
5.0
—
—
—
0
0
39
273
1.46
1.39
7.5
6.6
—
—
—
0
0
40
282
1.45
1.38
2.2
1.8
—
—
—
0
0
83
660
1.30
1.38
1.9
2.7
122.53
120.43
ug/g
0.02
67
531
171
1955
0.82
1.38
3.5
3.0
—
—
—
0
0
135
1141
1.24
1.37
4.4
3.6
1.01
1.02
kg/l
0.51
89
757
6
23
2.63
1.37
1.2
1.7
—
—
—
0
0
54
404
1.37
1.35
1.1
1.2
—
—
—
0
0
39
276
1.44
1.33
3.1
1.7
0.36
0.34
mg/l
0.07
22
138
6
24
2.52
1.30
1.0
1.4
160.50
154.89
nmol/l
—
6
24
53
399
1.36
1.28
6.2
4.3
7.37
7.34
ph
0.70
37
290
9
44
2.06
1.27
2.3
2.0
—
—
—
0
0
12
63
1.92
1.23
1.5
1.3
—
—
—
0
0
496
4798
1.32
1.22
20.7
13.4
—
—
—
0
0
47
351
1.37
1.20
4.4
3.6
—
—
—
0
0
47
352
1.37
1.18
5.6
3.7
7.41
7.42
ph
0.31
39
290
49
370
1.36
1.18
3.0
2.4
5.80
8.47
ug/l
0.76
44
337
100
833
1.24
1.16
2.2
3.0
2.45
2.44
mmol/l
0.18
91
755
35
250
1.43
1.16
5.8
3.9
—
—
—
0
0
83
681
1.26
1.10
1.4
1.4
320.00
420.29
titre
0.47
12
140
22
145
1.54
1.07
1.0
1.1
—
—
—
0
0
457
4394
1.23
1.06
5.3
4.8
6.21
5.94
mmol/l
2.16
419
4086
14
82
1.73
1.06
7.4
6.3
427.64
370.04
umol/l
0.52
14
71
43
325
1.35
1.04
6.2
4.1
1.21
1.23
mmol/l
0.61
36
288
5
106
0.47
1.02
2.6
4.9
—
—
—
0
0
47
363
1.32
1.00
5.7
3.7
5.32
5.09
kpa
0.97
42
351
5
23
2.18
0.98
1.2
1.2
5.15
6.84
mmol/l
—
5
23
12
198
0.60
0.97
1.8
1.9
179.08
220.31
pmol/l
0.73
12
185
9
50
1.81
0.97
2.3
2.2
—
—
—
0
0
19
125
1.54
0.95
1.5
1.5
41989.57
7908.48
e6/l
1.32
14
91
14
85
1.66
0.95
1.3
1.4
—
—
—
0
0
15
93
1.63
0.94
1.1
1.1
—
—
—
0
0
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
9
52
1.74
0.92
1.3
1.5
101.20
31.47
ng/l
—
9
52
368
3489
1.16
0.92
4.6
4.0
14.50
14.70
pmol/l
0.90
339
3205
6
29
2.08
0.89
1.2
1.8
—
—
—
0
0
6
29
2.08
0.89
2.5
1.3
—
—
—
0
0
24
169
1.44
0.89
1.2
1.3
—
—
—
0
0
16
103
1.57
0.88
1.3
1.3
—
—
—
0
0
19
128
1.50
0.87
2.1
1.3
—
—
—
0
0
476
4620
1.22
0.85
5.9
5.5
2.65
2.73
mmol/l
1.18
447
4340
8
46
1.75
0.83
1.0
1.0
—
—
—
0
0
8
46
1.75
0.83
1.3
1.1
—
—
—
0
0
52
420
1.26
0.82
6.2
5.1
0.47
0.98
%
1.84
17
140
11
66
1.68
0.79
1.9
1.9
—
—
—
0
0
13
82
1.60
0.78
1.6
1.6
—
—
—
0
0
156
1407
1.15
0.77
3.4
3.1
0.06
0.07
estimate
0.03
49
399
9
53
1.71
0.75
1.0
1.0
—
—
—
0
0
98
855
1.18
0.74
1.7
1.7
—
—
—
0
0
16
230
0.69
0.73
2.3
1.6
—
—
—
0
0
49
399
1.25
0.73
5.9
4.9
0.35
0.56
%
0.61
17
128
5
26
1.93
0.71
5.4
2.4
—
—
—
0
0
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
12
77
1.57
0.69
1.3
1.2
—
—
—
0
0
15
102
1.48
0.68
1.3
1.3
—
—
—
0
0
24
179
1.36
0.68
3.9
2.5
5635.70
5770.88
u/l
—
10
68
7
43
1.64
0.67
2.4
2.8
—
—
—
0
0
211
1958
1.13
0.67
1.9
1.9
1.44
1.39
mmol/l
0.33
171
1684
36
448
0.79
0.66
3.1
4.8
13.83
23.00
ug/l
0.29
29
371
101
893
1.16
0.65
4.9
4.0
134.27
435.72
ng/l
1.59
80
684
11
70
1.58
0.65
1.0
1.2
—
—
—
0
0
78
677
1.18
0.64
1.7
1.7
—
—
—
0
0
49
407
1.22
0.63
6.9
5.6
0.17
0.12
%
0.09
12
107
8
49
1.64
0.62
1.3
4.8
8.65
11.32
%
—
8
49
18
130
1.40
0.62
2.7
1.8
—
—
—
0
0
47
390
1.22
0.62
3.8
2.5
0.29
0.23
e6/l
0.18
47
373
26
200
1.31
0.61
1.3
1.4
—
18.56
—
0
5
5
30
1.67
0.61
1.4
1.2
—
—
—
0
0
28
218
1.30
0.61
7.6
3.7
24.95
25.01
mmol/l
0.03
28
210
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
517
5088
1.24
0.60
34.8
23.2
248.99
247.33
e9/l
0.23
512
5005
0
22
0.00
0.59
0.0
6.1
—
8.18
—
0
22
0
22
0.00
0.59
0.0
3.0
—
45.36
—
0
22
155
1423
1.12
0.58
1.5
1.4
—
—
—
0
0
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
8
54
1.49
0.57
1.1
1.7
88.69
89.99
%
—
8
54
498
4887
1.19
0.57
14.2
11.8
26.68
28.39
u/l
1.54
488
4775
47
394
1.21
0.57
6.6
5.3
0.00
0.15
%
3.54
12
112
517
5091
1.23
0.57
34.8
23.2
4.48
4.58
e12/l
4.09
512
4993
517
5092
1.23
0.56
34.8
23.2
6.97
6.70
e9/l
2.28
512
4993
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
114
1031
1.13
0.55
2.1
2.1
—
—
—
0
0
14
99
1.42
0.54
1.1
1.1
—
—
—
0
0
14
99
1.42
0.54
4.6
3.2
—
—
—
0
0
148
1362
1.12
0.54
3.0
2.8
—
0.09
—
0
23
9
62
1.46
0.53
1.4
1.2
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
37
306
1.22
0.52
1.3
1.3
196.76
129.63
u/ml
0.32
16
124
467
4574
1.13
0.48
5.5
4.9
4.47
4.59
mmol/l
1.76
441
4313
105
1151
0.89
0.47
2.8
3.1
0.66
0.76
ug/l
0.77
74
716
5
82
0.61
0.46
1.0
1.1
—
6.85
u/ml
—
0
38
23
285
0.80
0.44
1.0
1.1
—
—
—
0
0
8
56
1.43
0.42
1.6
1.4
—
—
—
0
0
12
87
1.39
0.42
1.2
1.3
2.86
4.41
u/ml
—
7
41
67
597
1.14
0.42
3.2
3.1
4.08
5.60
e9/l
0.92
61
532
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
50
437
1.16
0.41
1.3
1.6
—
—
—
0
0
93
849
1.11
0.40
1.3
1.3
32.34
28.83
iu/ml
0.11
25
253
8
112
0.71
0.37
1.1
1.1
—
—
—
0
0
8
112
0.71
0.37
1.1
1.1
—
—
—
0
0
6
43
1.40
0.35
1.0
1.8
—
—
—
0
0
6
43
1.40
0.35
1.0
1.5
—
—
—
0
0
21
172
1.23
0.34
2.0
1.9
—
—
—
0
0
6
44
1.37
0.34
1.2
1.4
—
—
—
0
0
6
44
1.37
0.34
1.0
1.8
—
—
—
0
0
10
133
0.75
0.34
1.6
1.7
—
—
—
0
0
15
119
1.27
0.32
1.9
1.4
124.13
151.76
au/ml
—
8
36
24
283
0.84
0.31
19.5
12.1
14.70
15.84
%
1.39
24
271
11
84
1.32
0.30
2.9
4.7
14.55
425.89
u/ml
0.81
11
78
25
213
1.18
0.29
1.4
1.4
17.66
20.93
iu/l
0.27
20
178
463
4563
1.09
0.29
5.3
4.8
1.36
1.40
mmol/l
1.59
433
4282
22
186
1.19
0.28
1.6
2.7
—
—
—
0
0
59
541
1.10
0.26
1.6
1.5
—
—
—
0
0
58
532
1.10
0.25
2.0
1.8
—
—
—
0
0
23
198
1.17
0.25
1.1
1.4
267.86
254.20
miu/ml
—
7
101
9
76
1.19
0.24
1.2
1.6
—
—
—
0
0
9
76
1.19
0.24
1.2
1.6
—
—
—
0
0
9
76
1.19
0.24
1.2
1.6
—
—
—
0
0
9
76
1.19
0.24
1.2
1.6
—
—
—
0
0
55
596
0.91
0.23
1.9
2.4
12.38
13.74
nmol/l
0.61
48
547
182
1754
1.06
0.22
2.2
2.1
—
—
—
0
0
65
605
1.08
0.22
1.6
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.8
—
1.21
—
0
11
0
10
0.00
0.21
0.0
1.1
—
0.05
—
0
10
12
98
1.23
0.21
6.4
3.3
55.53
59.38
%
0.48
12
98
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.2
1.4
—
—
nmol/l
—
0
0
40
437
0.91
0.20
1.9
1.7
3.48
3.55
mmol/l
0.16
27
323
6
50
1.20
0.19
1.5
1.3
—
—
—
0
0
15
128
1.18
0.18
2.5
3.3
2.22
2.49
index
—
9
78
7
61
1.15
0.17
1.0
1.3
—
112.54
—
0
5
30
327
0.91
0.15
2.5
2.5
16.33
14.54
au/ml
—
7
30
9
83
1.09
0.14
1.1
1.2
—
—
—
0
0
23
209
1.10
0.13
1.4
1.3
—
—
—
0
0
33
307
1.08
0.12
1.3
1.2
—
—
—
0
0
81
779
1.05
0.12
1.3
1.3
0.99
9.32
u/ml
4.05
23
313
12
136
0.88
0.11
1.1
1.2
—
3.30
—
0
15
439
4358
1.04
0.10
4.6
4.2
1.35
1.31
mmol/l
0.61
407
4069
17
187
0.91
0.10
1.3
1.2
—
—
—
0
0
5
46
1.09
0.09
2.8
1.2
—
—
—
0
0
5
47
1.06
0.09
1.0
1.4
203.16
178.87
pmol/l
—
5
47
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
5
65
0.77
0.08
2.6
3.1
—
—
—
0
0
7
64
1.09
0.08
2.1
2.4
—
—
—
0
0
7
68
1.03
0.08
9.6
2.6
—
—
—
0
0
6
70
0.86
0.07
9.5
3.6
4.68
4.46
e9/l
—
6
70
14
153
0.91
0.07
6.5
11.4
—
—
—
0
0
8
95
0.84
0.06
1.9
1.4
—
—
—
0
0
9
102
0.88
0.06
1.0
1.2
55.17
27.33
u/l
—
9
89
188
1904
0.98
0.06
5.0
5.0
2.03
2.21
ug/l
0.27
176
1733
40
385
1.04
0.06
1.4
1.5
—
—
—
0
0
12
130
0.92
0.04
1.2
1.3
—
—
—
0
0
21
200
1.05
0.04
1.0
1.1
—
—
—
0
0
62
607
1.02
0.03
1.2
1.3
—
—
—
0
0
20
209
0.96
0.03
1.1
1.2
0.89
0.91
g/l
0.15
20
209
54
549
0.98
0.02
1.4
1.4
—
—
—
0
0
21
217
0.97
0.01
2.5
2.3
—
—
—
0
0
13
127
1.02
0.00
1.6
1.6
78.38
58.58
ug/l
0.56
13
110
11
109
1.01
0.00
1.1
1.2
—
—
—
0
0
20
199
1.01
0.00
1.1
1.1
1.59
1.50
g/l
0.84
20
199
0
7
0.00
0.00
0.0
3.3
—
1.01
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
1.99
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
98
0.92
0.00
1.9
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
402.00
—
0
5
6
59
1.02
-0.00
1.0
1.1
—
—
—
0
0
7
78
0.90
-0.00
1.9
2.1
3.81
5.45
mmol/24h
—
7
70
0
8
0.00
-0.00
0.0
1.3
—
77.46
—
0
8
0
5
0.00
-0.00
0.0
3.0
—
189.80
—
0
5
0
9
0.00
-0.00
0.0
5.2
—
6.79
—
0
9
5
52
0.96
-0.00
1.0
2.7
19.40
23.60
nmol/l
—
5
47
0
5
0.00
-0.00
0.0
1.0
—
73.46
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
40.00
—
0
6
0
9
0.00
-0.00
0.0
5.6
—
11.07
—
0
9
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
93
0.97
-0.00
6.1
2.9
10.52
8.84
pmol/l
—
9
93
0
5
0.00
-0.00
0.0
1.0
—
19.70
—
0
5
0
9
0.00
-0.00
0.0
1.6
—
68.67
—
0
9
0
5
0.00
-0.00
0.0
5.8
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_BURN_CORROSION_ANKLE_FOOT – Burn and corrosion of ankle and foot

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).